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Abstract
Marijuana is the most common illicit drug that is abused by pregnant women, and
recently many states have adopted various levels of relaxed marijuana policies. The
purpose of this study was to evaluate a potential association between residing in a state
that allows medical marijuana use and maternal marijuana usage. Grounded in the theory
of planned behavior, this study evaluated the prevalence and extent of maternal marijuana
use in states that allow and states that do not allow medical marijuana use using the
National Survey of Drug Use and Health (NSDUH). It was anticipated that more lenient
subjective norms toward marijuana use and increased availability would support an
increase of maternal marijuana use. The 2014 NSDUH was queried and analyzed using
chi-square and logistic regression. The study revealed an increase of maternal marijuana
use in states where medical marijuana was allowed, but the increase was not statistically
significant. An increase of heavy users was observed in states where medical marijuana
was allowed (54% versus 37%). Consistent with other research findings, this study
revealed that young (OR = 3.56; 95% CI: 1.379, 9.213; p = 0.009) and unmarried (OR =
6.81; 95% CI: 2.485, 18.661; p < 0.001) pregnant woman were at higher risk for past
month maternal marijuana use and had similar results for past year use. The unintended
consequences of increased in utero marijuana exposure and its subsequent negative
public health effects have been missing from the discussion of the relaxation of statewide
marijuana policies. This study will provide policy makers responsible for changing
marijuana policy with useful evidence on the unintended consequences of increased
maternal marijuana use in areas where medical marijuana is allowed.
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Chapter 1: Introduction to the Study
Maternal substance misuse continues to be a significant public health concern
with no statistically significant improvement in maternal abstinence over the past 2
decades (Creanga et al., 2012, Substance Abuse and Mental Health Services
Administration, 2014). Maternal substance misuse has been implicated in a number of
negative health outcomes including neonatal abstinence syndrome, disorders related to
short gestation and low birthweight (Creanga et al., 2012), and the teratogenic effects of
selected drugs or their metabolites (including marijuana) resulting in long-term
neurobehavioral deficits. (Minnes, Lang, & Singer, 2011).
To address this public health concern, one specific goal included in Healthy
People 2020 was to reduce the prevalence of prenatal substance exposure (Healthy
People 2020, 2016). Contrary to this objective is the national trend of statewide
marijuana laws policy relaxation (Morris, TenEyck, Barnes, & Kovandzic, 2014).
Policy makers should be fully informed of potential unintended consequences of allowing
medical marijuana use so that education, prevention, and intervention resources may be
directed to this vulnerable population. In this study, I evaluated the effect of statewide
marijuana policy relaxation on maternal marijuana use patterns using a large national
population-based database. This chapter includes the background of maternal marijuana
use and the study design including the gap in the literature, the purpose of the study,
research questions, and hypotheses. The chapter will include information on my use of
the theory of planned behavior as the theoretical foundation of this inquiry and a brief
description of the study design.
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Background
Although the overall prevalence of mothers using marijuana is low, maternal
marijuana use is a significant public health concern. Marijuana, a teratogen, has been
implicated as a source of a number of neurobehavioral deficits including diminished
academic skills, executive function impairments, and adolescent delinquency (Minnes,
Lang, & Singer, 2011, Ko, Farr, Tong, Creanga, & Callaghan, 2015). Between 1.2% and
4% of all pregnant women self-report consumption of marijuana during pregnancy;
however, this prevalence estimate is considered to be an underestimate due to recall bias
and deceit because of stigma and self-incrimination (Muhuri & Gfoerer, 2008; SaurelCubizolles, Prunet, & Blondel, 2014; Ko et al., 2015). The prevalence of maternal
marijuana use is inversely proportional to income and is more prevalent among women
not cohabiting with the father of the child (Saurel-Cubizolles et al., 2014; Ko et al.,
2015). The prevalence of maternal marijuana use does not appear to be associated with
the age of the mother (Saurel-Cubizolles et al., 2014; Roberson, Patrick, & Hurwitz,
2014).
Prenatal exposure to marijuana has not been shown to be consistent with neonatal
outcome deficits such as low birthweight or small head circumference, but it has been
shown to be associated with a number of neurobehavioral deficits (Hingson et al., 1986;
Zuckerman et al., 1989; Conner, Carter, Tuuli, Macones, & Cahill, 2015). Deficits, such
as increased tremors and startles, may be detected soon after birth and are reflective of
cognitive and behavioral deficits, such as poorer academic skills and negative adolescent
behaviors, which may appear later in life (Minnes et al., 2011). Additionally, children
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exposed to marijuana in utero are more apt to engage in marijuana use, with female
children being more likely to repeat the cycle of maternal marijuana use (Day,
Goldschmidt, & Thomas, 2006).
In 1996, California passed a law allowing for the medicinal use of marijuana
under certain controlled circumstances (Morris et al., 2014). Since then, over 20 states
introduced laws of varying levels of policy relaxation, from allowance of marijuana for
medical use up to full commercialization (Morris et al., 2014). There are many different
variants of these laws, such as allowance of home cultivation, registration of users,
allowance of distribution, and provision for dispensaries (Pacula, Powell, Heaton, &
Sevigny, 2015). As of 2016, almost every state has either implemented a relaxed policy
or has pending legislation for policy relaxation in progress (Maxwell & Mendelson,
2016). Studies on the effects of changes to these policy modifications will be discussed
in detail later in this section and in Chapter 2.
The theory of planned behavior provides a clear logistic model of health behavior
including initiation, maintenance, and cessation of drug use and misuse (Ajzen, 1991).
Ajzen (1991) theorized that a behavior occurs following the intention to perform the
behavior, and further theorized that behavioral attitudes, subjective norms, and perceived
behavioral control influence intention.
The use of marijuana requires several acts of intention from obtaining the drug,
preparing the drug for use (such as rolling a cigarette, packing a pipe, or baking a
brownie), and eventually consuming the drug. Behavioral attitude reflects how the
individual feels about performing a particular behavior such as the health risk of
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performing a behavior or whether it makes them feel good or bad (Ajzen, 1991).
Subjective norms describe the individual’s perception of how others feel about the
performance of a behavior, for example, the individual’s perception of how their friends,
parents, or community feel about their maternal marijuana use (Ajzen, 1991). Perceived
behavioral control describes the individual’s perception of how easy or difficult
performing a behavior would be. In this example, that would encompass the perceived
ease of obtaining marijuana or overcoming the cravings of addiction (Ajzen, 1991).
The effect of statewide policy acceptance on subjective norms and perceived
behavioral control is clear and self-evident (Pacula et al., 2015). Wall and colleagues,
using responses from the 2002-2008 NSDUH study, reported that the presence of medical
marijuana laws were associated with higher rates of self-reported marijuana use in young
adults and adolescents (Wall et al., 2011). Other national survey data sets (National
Epidemiologic Survey on Alcohol and Related Conditions-Second Wave and the 19912011 Youth Risk Behavior Survey) determined that while this observation existed it was
not attributable merely to the presence of the medical marijuana laws (Cerda, Wall,
Keyes, Galea, & Hasin, 2012; Choo et al., 2014). Missing from the literature is a study
evaluating the potential associations between increased marijuana usage and pregnant
women. To address this gap in the literature this study will evaluate a large national
population-based survey, the NSDUH, and group those results to the various statewide
policies of the primary state of residence for the pregnant respondents. With long-term
negative health consequences associated with prenatal marijuana exposure, understanding
the factors leading to maternal marijuana use are very important.
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Problem Statement
Marijuana is the most common illicit drug abused by Americans, and is the most
commonly abused drug among pregnant women (Martin, Longinaker, Mark, Chisolm, &
Terplan, 2015). According to the National Survey on Drug Use and Health (NSDUH)
almost 4% of pregnant women self-report using marijuana within the past 30 days (Ko et
al., 2015). The results of prior studies concerning the negative health effects of prenatal
marijuana exposure and neonatal outcomes (such as low birthweight, short birth length,
and small head circumference) have not been consistent (Conner et al., 2015). More
recently, researchers have focused on long term neurobehavioral consequences of
prenatal marijuana exposure presenting in adolescence including altered neural
functioning, emotional deficits, behavioral deficits, low academic achievement, and
increased risk of substance misuse (Minnes et al., 2011).
Current trends and societal norms regarding marijuana use are becoming more
accepting and many states have adopted various levels of relaxed marijuana policies
(Pacula et al., 2015). California passed the first medical marijuana law in 1996 and 10
other states followed suit over the following decade (Morris et al., 2014). Following a
ballot initiative in 2012, Colorado implemented a 2014 law allowing full
commercialization and recreational use of marijuana (Hawken, Caulkins, Kilmer, &
Kleiman, 2013). By 2016, almost every state in the United States had created some form
of marijuana law relaxation or had legislation pending (National Alliance for Model State
Drug Laws, 2016). Specifically, during the 2014 survey year, 19 states plus the District
of Columbia had established marijuana laws permitting use for medicinal purposes, with
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three additional states approving medical marijuana throughout the survey year, 2014
(Table 1). With the establishment of these policies, licensed marijuana growers have
been able to operate in an open market environment. With these changes, the potency of
marijuana has risen significantly over the past 2 decades (ElSohly et al., 2016).
The association between societal norms and marijuana use has been studied
within the framework of several health behavior theories but the most prevalent theory
that has been utilized is the theory of planned behavior. This is primarily because of the
robustness provided by the inclusion of perceived behavioral control construct (Ito,
Henry, Cordova, & Bryan, 2015). The association between relaxed societal norms and/or
perceived behavioral control and increased marijuana usage has been demonstrated in a
number of vulnerable groups such as adolescents (Wall et al., 2011), Mexican American
youths (Kam, Matsunaga, Hecht, & Ndiaye, 2009), and incoming college students (Ito et
al., 2015). In the current environment of social norm relaxation and increased access to
marijuana, warnings have been issued by those in the perinatology field that today’s
marijuana is much more potent than it was at any other time in history, and the long-term
health consequences for prenatal marijuana exposure have not been fully determined
(Warner, Roussos-Ross, & Behnke, 2014). However, studies of the association of
medical marijuana laws and maternal marijuana usage patterns are lacking from the
literature. The use of a large national population-based database such as the NSDUH to
compare maternal marijuana use patterns with medical marijuana laws may potentially
fill this gap in the literature.
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Table 1
Medical Marijuana Law by State at the Time of the 2014 NSDUH. Nineteen (19) States
Allowed Medical Marijuana Prior to the 2014 Survey and 3 States Passed a Medical
Marijuana Law During the Year of the Survey.
Medical Marijuana Law
Approved before 2014

State
Alaska, Arizona, California, Colorado,
Connecticut, Delaware, Hawaii, Illinois,
Maine, Massachusetts, Michigan, Montana,
Nevada, New Hampshire, New Jersey,
Oregon, Rhode Island, Vermont,
Washington, Washington DC.

Approved during 2014

Maryland, Minnesota, New York

Not Approved by 2014

Alabama, Arkansas, Florida, Georgia, Idaho,
Indiana, Iowa, Kansas, Louisiana, New
Jersey, North Carolina, North Dakota, New
Mexico, Missouri, Mississippi, Nebraska,
Ohio, Oklahoma, Pennsylvania, South
Carolina, South Dakota, Texas, Tennessee,
Utah, Virginia, West Virginia, Wisconsin,
Wyoming

Purpose of the Study
The purpose of this study was to evaluate whether there was an association
between self-reported marijuana usage of pregnant women residing in states where
medical marijuana was allowed, and marijuana usage of pregnant mothers residing in
states where medical marijuana was not allowed. A quantitative research design was
used to explore the prevalence and extent of maternal marijuana use from the responses
of self-reported pregnant women to a national population-based survey. Maternal
marijuana use was determined from the response to the question, “How long has it been
since you last used marijuana or hashish?” specifically self-reported pregnant respondents
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answering in the affirmative to past month use; and the question, “During the past year,
on how many days did you use marijuana or hashish?” The state level marijuana policy
was determined from the field indicating whether the respondent lived in a state where
medical marijuana was allowed or not allowed at the time of the interview. This study
compared survey responses from pregnant women who indicated marijuana use, amount
of use, and their designation of residing in a state that allows or does not allow medical
marijuana while controlling for age, race, ethnicity, education level, household income,
and marital status.
Research Question and Hypotheses
The research questions and hypotheses for this study were as follows:
Research Question 1: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is not
allowed?
H01: There is no difference between the proportions of pregnant women that selfreport marijuana use during the past 30 days living in states where medical
marijuana is allowed compared to states where medical marijuana is not allowed.
Ha1: There is a difference between the proportions of pregnant women that selfreport marijuana use during the past 30 days living in states where medical
marijuana is allowed compared to states where medical marijuana is not allowed.
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Research Question 2: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not allowed?
H02: There is no difference between the proportions of pregnant women that selfreport marijuana use during the past year living in states where medical marijuana
is allowed compared to states where medical marijuana is not allowed.
Ha2: There is a difference between the proportions of pregnant women that selfreport marijuana use during the past year living in states where medical marijuana
is allowed compared to states where medical marijuana is not allowed.
Research Question 3: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is not allowed
while controlling for the covariates age, income, race/ethnicity, educational level, and
marital status?
H03: There is no difference between the proportions of pregnant women
that self-report marijuana use during the past 30 days living in states
where medical marijuana is allowed compared to states where medical
marijuana is not allowed while controlling for the covariates age, income,
race/ethnicity, educational level, and marital status.
Ha3: There is a difference between the proportions of pregnant women
that self-report marijuana use during the past 30 days living in states
where medical marijuana is allowed compared to states where medical
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marijuana is not allowed while controlling for the covariates age, income,
race/ethnicity, educational level, and marital status.
Research Question 4: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not allowed while
controlling for the covariates age, income, race/ethnicity, educational level, and marital
status?
H04: There is no difference between the proportions of pregnant women
that self-report marijuana use during the past year living in states where
medical marijuana is allowed compared to states where medical marijuana
is not allowed while controlling for the covariates age, income,
race/ethnicity, educational level, and marital status.
Ha4: There is a difference between the proportions of pregnant women
that self-report marijuana use during the past year living in states where
medical marijuana is allowed compared to states where medical marijuana
is not allowed while controlling for the covariates age, income,
race/ethnicity, educational level, and marital status.
Research Question 5: Is there a difference in the prevalence of pregnant women that selfreport heavy marijuana use compared to light marijuana use during the past year for
women living in states that allow medical marijuana use and women living in states that
do not allow medical marijuana use?
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H05: The prevalence of pregnant women that report heavy marijuana use
compared to pregnant women that report light marijuana use during the
past year is not different for women living in states that allow medical
marijuana use and women living in states that do not allow medical
marijuana use.
Ha5: The prevalence of pregnant women that report heavy marijuana use
compared to pregnant women that report light marijuana use during the
past year is different for women living in states that allow medical
marijuana use and women living in states that do not allow medical
marijuana use.
Conceptual Framework
Several health behavioral models have been developed for the purpose of
understanding and predicting drug use initiation, abuse, addiction, and cessation, but the
model that has been the most useful is the theory of planned behavior (Conner &
McMillan, 1999). Understanding these behaviors through the lens of a theoretical
framework allows substance abuse treatment professionals to design and implement
focused and more effective intervention efforts (Ajzen, 1991). Although designed for
understanding any health behavior, there are many examples in the literature of the theory
of planned behavior’s usefulness in understanding drug use initiation and drug use
maintenance (Conner & McMillan, 1999). The cornerstone of the theory is the construct
that an intention to perform a particular behavior must exist prior to performing the
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behavior, and that several key factors predict the magnitude of the intention (Ajzen,
1991).
The theory of planned behavior evolved from the theory of reasoned action,
which states that intention to perform a behavior is predicted by two factors: attitudes and
subjective norms (Ajzen & Madden, 1986). Ajzen (1991) stated that the magnitude of the
intention to perform a behavior was predictive of the likelihood of performing the
behavior. Attitudes refer to the personal belief of the outcome associated with
performing the behavior, whereas subjective norms refer to the perceived acceptance of
the behavior by others (Ajzen & Madden, 1986). This model was successful with the
prediction of behaviors that were under the willful or volitional control of the individual,
however, the effectiveness of the model was limited in situations where behaviors were
not under volitional control (Ajzen, 1991).
To address this limitation, Ajzen (1991) extended the theory of reasoned action to
include perceived behavioral control as an additional factor. Perceived behavioral control
describes the belief of the individual of their control over performing the behavior (Ajzen
& Madden, 1986). This expanded framework was named the theory of planned behavior.
It was expected that the relaxation of state policy toward marijuana use will influence
intentions through all three mechanisms: attitudes, subjective norms, and perceived
behavioral control.
Nature of the Study
Research was conducted using a secondary data analysis from the 2014 NSDUH
to investigate the association between maternal marijuana use patterns and statewide
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marijuana policy in the United States. The NSDUH is a population-based national survey
conducted periodically by the Substance Abuse and Mental Health Administration
(SAMHSA; Center for Behavioral Health Statistics and Quality, 2015). The primary
purpose of the NSDUH is to survey the drug, tobacco, and alcohol use patterns of United
States citizens (non-institutionalized civilians), ages 12 years old and over (Center for
Behavioral Health Statistics and Quality, 2015). The cross sectional study presented here
was a quantitative design.
The category of state marijuana policy was indicated by the field noting that the
state of primary residence allows or does not allow the use of medical marijuana at the
time of the interview. Only women that responded in the affirmative to the question of
current pregnancy were included in the study. Maternal marijuana use was assigned to
individuals who selected the responses, “within the past 30 days” and “more than 30 days
but within the past 12 months” to the question, “How long has it been since you last used
marijuana or hashish?” The amount of consumption will be determined by the responses
to the questions: “On how many days during the past 12 months did you use marijuana or
hashish?” and “What is your best estimate of the number of days you used marijuana or
hashish during the past 30 days?” The responses to questions of marijuana use of
pregnant women from the state medical marijuana policy category will be compared
using chi-squared and logistic regression to evaluate for differences and associations of
use and frequency of use.
Definitions
This section defines several terms that were utilized in this study:
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Attitude: The feeling (good or bad) that an individual has concerning performing
a behavior (Ajzen & Madden, 1986).
Cannabis: refers to the cannabis sativa plant
Hashish and hashish oil: An extracted product of the cannabis sativa plant.
Marijuana: Material obtained from the cannabis sativa plant. It may be prepared
for smoking in small cigarettes (joints), large cigars (blunts), smoked in a pipe or
incorporated into foodstuffs.
Neurobehavioral: Pertaining to the association between the nervous system and
behavior, typically the behavioral disorders resulting from nervous system development
deficits or damage.
Perceived behavioral control: The perceived control of performing a behavior by
the individual such as the ability to perform the behavior, control over performing it, and
access to the resources needed to perform the behavior (Ajzen & Madden, 1986).
Subjective norm: The individual’s concern associated with how others (mate,
friends, parents, etc...) think about the individual performing a behavior (Ajzen &
Madden, 1986).
Theory of planned behavior: This popular theory of health behavior infers that an
individual must exhibit an intention to perform a behavior prior to performing the
behavior. The magnitude of the intention predicts the likelihood of performing the
behavior. Intention is influenced by 3 main factors – attitude, subjective norms, and
perceived behavioral control (Ajzen & Madden, 1986).
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Study Assumptions
A number of assumptions were required in order to accept the study results. First,
the NSDUH survey team utilized a complex sampling method to select participants of the
survey. I assumed this sampling method provided adequate representation of a
nationwide population. Second, I assumed that the participants answered the survey
truthfully and that the survey staff recorded those responses accurately. Lastly, I
assumed that the statewide medical marijuana policy of the primary state of residence
was the source of most influence which is an obvious limitation for those living very near
the border of states with different policies.
Scope and Delimitations
The scope of the study was the association of statewide medical marijuana policy
relaxation and maternal marijuana use patterns. The study was limited to female
respondents that reported in the affirmative to the question of current pregnancy in the
2014 NSDUH national survey (Research Triangle Institute, RTI, 2013). The study did
not include women that were institutionalized or unaware of their pregnancy (RTI, 2013).
The study only included women that were currently pregnant and did not report the
results of women who had recently given birth (RTI, 2013).
Study Limitations
The study was limited in a number of ways which must be considered. First, this
study was a cross sectional design, which did not allow for the establishment of
causation. Second, the study relied on self-report to determine maternal drug use
patterns. Self-report methods of data collection are a limitation due to recall bias,
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memory loss, and deception, both of which may be have been increased due to the
potential stigma for this target population. Lastly, the NSDUH only surveys
noninstitutionalized individuals living in a civilian household; therefore, this database
does not include the imprisoned or those in the military (RTI, 2013).
Significance of the Study
Currently, no study or evaluation of statewide marijuana policy relaxation and its
association to maternal marijuana usage exist. This study aims to fill this gap in the
literature by comparing marijuana use patterns of pregnant women in states where
medical marijuana use is allowed and states where medical marijuana is not allowed.
The unintended consequences of increased in utero marijuana exposure and its
subsequent negative public health effects have been missing from the discussion of the
relaxation of statewide marijuana policies. This objective evaluation will provide useful
evidence for stakeholders responsible for changing marijuana policy.
Summary
Prenatal marijuana exposure is associated with a number of negative
neurobehavioral outcomes (Minnes et al., 2011). Statewide marijuana policy relaxation
gives pregnant women tacit approval and increased access to marijuana use, which is
contrary to an objective of Healthy People 2020 to reduce maternal substance use
(Healthy People 2020, 2016). Chapter 2 will provide a more detailed examination of the
literature regarding the epidemiology of maternal marijuana use and negative public
health consequences of prenatal marijuana exposure. In Chapter 2, discussions about the
relationship between statewide marijuana policy relaxation and a popular health behavior
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model, the theory of planned behavior and its effect on the increase in marijuana potency
over time will occur. Chapter 3 will dive deeper into the research design and statistical
analysis of the NSDUH dataset. Findings of the analysis will be explored in Chapter 4,
and Chapter 5 will summarize these findings, compare them to current extant literature,
and frame future recommendations.
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Chapter 2: Literature Review
Introduction
Chapter 2 will examine peer-reviewed scientific literature pertaining to prenatal
marijuana exposure, neonatal outcomes, marijuana potency trends, and the effect of
statewide policy on marijuana usage. The literature review contains five sections:
literature search strategy, prevalence of maternal marijuana usage, the negative
associations of prenatal marijuana exposure, the effect of statewide policy on marijuana
usage, and trends in marijuana potency. A summary will clarify the proposed problem
statement and identify a gap in the current literature.
Literature Search Strategy
Search engines Google Scholar, PubMed, and EBSCOhost were utilized during
this literature search. Key search terms used to query the databases were: maternal
marijuana prevalence; prenatal marijuana exposure; prenatal marijuana exposure AND
neonatal morbidity; prenatal marijuana exposure AND neonatal outcome; prenatal
marijuana exposure AND preschooler; prenatal marijuana exposure AND adolescence;
marijuana law AND marijuana use; marijuana law AND adolescence; theory of planned
behavior; and theory of planned behavior AND marijuana. My search identified an
excess of 100 references spanning 35 years with additional pertinent references selected
through citation chaining. For inclusion purposes, articles must have appeared in a peerreviewed journal and be written in English. Due to the limited number of prospective
studies of prenatal marijuana exposure, seminal works concerning the teratogenic effects
of prenatal marijuana exposure from as early as 1980 were included in this review, while
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the remaining search terms were limited to 2010 to 2016. I excluded conference reports
and abstracts from the literature review.
Prevalence of Maternal Marijuana Use
The search strategy revealed four recent and pertinent studies on the prevalence of
maternal marijuana use in various populations. Muhuri and Gfoerer (2008) pooled the
marijuana use related results from the 2002-2006 NSDUH, which included the responses
of 94,838 women of reproductive-age. Of these, 5,017 women were pregnant at the time
of questioning. Saurel-Cubizolles, Prunet, and Blondel (2014) used France’s National
Perinatal Survey to survey 14,681 women on their marijuana use during a single week in
March 2010. Roberson, Patrick and Hurwitz (2014) used a similar mechanism to
evaluate the responses of 4,735 respondents from the State of Hawaii using the 20092011 Hawaii Pregnancy Risk Assessment Monitoring System (PRAMS), an operational
element of the Center of Disease Control and Prevention’s (CDC) national PRAMS
surveillance of pregnancy. Lastly, Ko, Farr, Tong, Creanga, and Callaghan (2015) used a
pooled NSDUH data set (2007-2012), which reviewed the answers from 4,971 pregnant
respondents and 88,402 non-pregnant women of reproductive-age. All of these studies
indicated that pregnant women, in general, are a low prevalence substance using group.
The distribution of self-reported use among pregnant women, specifically age, income
level, marital status, and race/ethnicity are examined in the next few sections.
Overall Prevalence
Overall, the reported prevalence of maternal marijuana use has been low across
several different groups. Muhuri and Gfoerer’s (2008) evaluation of 5 years of NSDUH
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data revealed that 2.8% (95% CI: 2.3, 3.3) of pregnant women in the United States selfreported the use of marijuana in the past 30 days. Saurel-Cubizolles et al. (2014)
reported that 1.2% (95% CI: 0.1, 3.0) of pregnant French women consumed marijuana in
the past 30 days. The Hawaii PRAMS surveillance showed that 2.6% (95% CI: 2.2, 3.2)
of pregnant Hawaiian women self-reported the use of marijuana during any time during
the pregnancy (Roberson et al., 2014). Ko et al. (2015) reported that 3.9% (95% CI: 3.2,
4.7) of pregnant women responding to the 2007-2012 NSDUH reported using marijuana
in the past 30 days. Although there are small differences in these prevalence findings,
ultimately the 95% confidence intervals overlap, which suggests that between these
populations the findings are not significantly different.
Maternal Age
The distribution of self-reported maternal marijuana use by age was inconsistent
and if differences were observed the observation was statistically insignificant. When
compared to 25-34 year old pregnant French women (the reference group), those less
than 25 years old self-reported less marijuana use (OR = 0.93; 95% CI: 0.60, 1.44) and
those older than 35 years old were slightly more at risk (OR = 1.25; 95% CI: 0.78, 2.01)
to self-report marijuana use. Both observations were not statistically significant as the
95% confidence intervals included unity (Saurel-Cubizolles et al., 2014). Roberson et al.
(2014) observed a small negative association between age and percentage of self-reported
use during pregnancy for pregnant women less than 20 years old, 20-24 years old, 25-29
years old, 30-34 years old, and greater than 35 years old reporting 3.2%, 3.6%, 1.9%,
2.6%, and 2.1%, respectively; however, this trend was not significant (P = 0.196). Ko et
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al. (2015) reported that younger pregnant women (18-25 years old) were 1.48 (95% CI:
0.8-2.6) times higher to report marijuana use during pregnancy; however, this finding
was insignificant due to the 95% confidence interval including unity. Muhuri and
Gfoerer (2008) did not report maternal marijuana use by age in their study.
Household Income
The association between self-reported maternal marijuana use and income is
negative and, when calculated, the trend is statistically significant. In a nationwide
survey of pregnant women in France, Saurel-Cubizolles et al. (2014) found a negative
trend in France between income and maternal marijuana use with those earning < 1000€
(OR = 2.68; 95% CI: 1.24, 5.82) and 1000-1499€ per month (OR = 2.52; 95% CI: 1.25,
5.08) when compared to those earning between 3000€ and 4000€ and the trend was
statistically significant (P > 0.05). Roberson et al. (2014) found a similar trend in the
United States using the United States federal poverty limit to categorize income level.
They found that 4.1% (95% CI: 3.1, 5.5) of those earning less than the federal poverty
limit self-reported the use of marijuana during pregnancy while those earning between
the poverty limit and two times the poverty limit was 2.2% (95% CI: 1.5, 3.3; Roberson
et al., 2014). Pregnant Hawaiian women with reported earnings greater than two times
the poverty limit was 2.0% (95% CI: 1.4-2.9), and this trend was statistically significant
(P = 0.007; Roberson et al., 2014). Ko et al. (2015) reported a negative association
between self-reported use and income, with < $20,000 (40.7%), $20,000-49,999 (34.2%),
$50,000-74,999 (13.2%) and > $75,000 (12.0%). Muhuri and Gfoerer (2008) did not
report maternal marijuana use by income in their study.
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Marital Status
When measured, marriage and cohabitation with the father of the child appeared
to have a negative association with maternal marijuana use. Saurel-Cubizolles et al.
(2014) reported that the French women who self-reported using marijuana during
pregnancy were less likely to be cohabitating with the father of their child (OR = 1.69;
95% CI: 1.01, 2.82; P < 0.05). Ko et al. (2015) reported that 70.4% (95% CI: 58.2, 80.3)
of pregnant self-reporting marijuana users from the 2007-2012 NSDUH surveys were
never married, while only 19.2% (95% CI: 11.7, 29.8) and 10.4% (95% CI: 4.4, 22.7)
were married or divorced, separated, or widowed, respectively. Muhuri and Gfoerer
(2008) and Roberson et al. (2014) did not report maternal marijuana use by marital status
in their studies.
Race/Ethnicity
The selected studies indicated that being in the racial/ethnic majority tended to be
associated with a higher likelihood of self-reported marijuana use. Muhuri and Gfoerer
(2008) showed a higher proportion of non-Hispanic Whites that self-reported marijuana
use during the past 30 days than non-Hispanic Black or Hispanic pregnant women (7.7%,
6.5%, and 3.8%, respectively). Roberson et al. (2014) demonstrated differences of
maternal marijuana usage between Hawaiian (2.8%; 95% CI: 2.1, 3.8), Asian (1.4%; 95%
CI: 0.8, 2.4), White (3.8%; 95% CI: 2.8, 5.3), and other/unknown (4.6%; 95% CI: 2.7,
7.7) ethnicities; these differences were statistically significant (P = 0.001). In their
nationwide French survey, Saurel-Cubizolles et al. (2015) reported that non-French
mothers self-reported much less marijuana use during pregnancy (OR = 0.19; 95% CI:
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0.08, 0.48; P < 0.001). Ko et al. (2015) showed that there was no statistical difference
between Whites (reference) and Non-Hispanic Blacks (OR = 0.90; 95% CI: 0.7, 1.1) and
a small protective factor for being Hispanic (OR = 0.6; 95% CI: 0.4, 0.8).
All four surveys found that pregnant mothers are typically a group that does not
readily self-report marijuana use. The surveys examined here showed no to little
variation based on age and minimal variation based on income and race/ethnicity. The
most striking differences of self-reported maternal marijuana use were observed when
comparing marital/cohabitation status where an approximate seven-fold difference was
reported between unmarried and married mothers.
The Consequences of Prenatal Marijuana Exposure
Prenatal Marijuana Exposure and Fetal Growth Deficits
Careful review of extant literature found six studies that evaluated prenatal
marijuana exposure and fetal growth characteristics such as birth length, birth weight, and
head circumference. Hingson et al. (1982) conducted a prospective study of 1,690 births
at Boston City Hospital using maternal self-reporting and a physical examination of the
newborn. Linn et al. (1983) reported on the Delivery Interview Program at Brigham and
Women’s Hospital in Boston in a prospective study that included interviews with 12,825
women about their substance use behaviors for mothers that delivered from 1977 to 1980.
Zuckerman et al. (1989) studied 1,226 mothers and infants recruited at the Women’s and
Adolescent Prenatal Clinics of Boston City Hospital between 1984 and 1987. Day et al.
(1991) evaluated prospectively 1,360 women randomly selected from the outpatient
clinic of Magee-Women’s Hospital and University of Pittsburg from 1983 to 1986.
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Hayatbakhsh et al. (2012) conducted a retrospective study of 24,874 births, inspecting
routine antenatal interviews and medical records from Mater Mother’s Hospital in
Brisbane, Australia from 2000 to 2006. Connor et al. (2015) retrospectively reviewed the
records of 8138 women that gave birth between 2004 and 2008 at St Louis Medical
Center.
Several of the reports mentioned above demonstrated an association between
prenatal marijuana exposure and a small reduction of birth length but not all found a
significant reduction. Zuckerman et al. (1989) observed a 0.52 cm (P = 0.02) reduction
in length at birth using a positive urinalysis result to categorize marijuana users from
nonusers. Day et al. (1991) found a 0.5 cm (P = 0.04) negative effect on birth length but
only for mothers who reported heavy usage (one joint per day on average) in the first
trimester. Mothers who reported heavy marijuana use in the second and third trimesters
did not produce statistically shorter newborns. Hayatbakhsh et al. (2012) reported a -1.3
cm (P< 0.01) birth length for mothers who self-reported marijuana use during pregnancy.
Hingson et al. (1982) did not report any significant difference in length following
prenatal exposure to marijuana.
Inconsistent findings for the association between prenatal marijuana exposure and
newborn birth weight dominate the literature. In a prospective study of 1,690 motherchild dyads in Boston, Hingson et al. (1982) revealed that marijuana was independently
associated with a 105g reduction of birth weight (P <0.01). Similarly, Zuckerman et al.
(1989) reported a birth weight decrease of 79g (P = 0.04) was associated with maternal
marijuana use when controlling for other drug use such as cocaine, opiates, alcohol, and
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tobacco. A much larger study of 12,424 women demonstrated that newborns prenatally
exposed to marijuana were more inclined to exhibit lower birth weight (OR = 1.07; CI
95%: 0.87, 1.31) but that finding was not significant (Linn et al., 1983). A large
retrospective study (Conner et al., 2015) of 8,138 live singleton births showed a similar
small effect on birth weight but that finding was also insignificant (OR = 1.3; CI 95%:
0.91, 1.8). At this time, no consistent evidence exists to support a negative effect of
prenatal marijuana exposure on birth weight.
Zuckerman et al. (1989) identified prenatal marijuana exposure using the
detection marijuana metabolites in maternal urine samples. Zuckerman and colleagues
reported a head circumference for prenatally exposed infants that were 0.9 cm (P <
0.001) less than those from non-using mothers. Hingson et al. (1982) and Day et al.
(1991) did not report any statistical differences in head circumference for newborns of
marijuana users compared to non-users.
Several explanations for the inconsistent observations of maternal marijuana use
and its effect on fetal growth characteristics have been proposed (English et al., 1997).
First, a random controlled trial administering measured doses of marijuana, an illicit
substance, to pregnant women is impossible from an ethical perspective. Some of the
studies were prospective but two of the larger studies were retrospective evaluations. All
of the studies utilized self-report with only one study using an objective urine assay in
tandem with self-report to classify users and non-users of marijuana. Self-report
strategies underestimate drug use because of social stigma and fear of legal repercussions
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(Hingson et al., 1986). The results from each study group may not be fully generalizable
due to socioeconomic status, geographic location, and cultural differences.
Prenatal Marijuana Exposure and Neonatal Neurobehavioral Outcomes
My literature search revealed several studies that demonstrated an association
between prenatal marijuana exposure and neonatal neurological deficits. One of the first
studies to evaluate the potential effects of prenatal marijuana exposure objectively was
conducted in Ottawa, Canada, where 291 women were questioned about their drug using
patterns and their newborns were evaluated for neurobehavioral competency using the
Neonatal Behavioral Assessment Scale (NBAS; Fried, 1980). In a larger follow up study,
Fried and Makin (1987) examined 250 Canadian mothers and babies, carefully
documenting the exposure to not only marijuana but alcohol and tobacco as well. Scher,
Richardson, Coble, Day, and Stoffer (1988) studied the sleep patterns of 55 newborns
that were selected due to prenatal exposure to marijuana or alcohol with matching
unexposed controls. Lester and Dreher (1989) reported on the abnormal cry patterns of
20 marijuana exposed newborns with matching controls in a study from Jamaica.
The Maternal Lifestyle Study approached over 19,000 pregnant mothers with the
primary intent to recruit 658 infants exposed to cocaine or opiates and 730 controls in
order to conduct detailed maternal lifestyle interviews and thorough physical examination
of the neonates but they were also able to report interesting findings associated with
prenatal marijuana exposure (Lester et al., 2002). A similar study from Sao Paulo, Brazil
recruited 26 marijuana exposed infants with matching controls (de Moraes Barros, 2006).
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The reported neurobehavioral deficits are expressed through abnormal responses to
stimuli, sleep disturbances, and abnormal cry patterns.
The effects of toxic agents on the development of central nervous system
functionality may be observed as abnormal reflexes or responses to external stimuli
(Minneset al., 2011). Brazelton’s NBAS was developed as a standardized measure of the
status of the neonate’s autonomic, motor, state, and social-attention development
(Brazelton & Nugent, 2011). NBAS consists of 28 behavioral tests that are scored by
trained evaluators using a nine-point scale (Brazelton & Nugent, 2011).
Two NBAS items reported with abnormal occurrence by Fried (1980) and Fried
and Makin (1987) for prenatal marijuana exposure was an increased number of startles
and tremors. Startles (a defensive reflex action that includes the sudden contraction of
the legs and arms) and tremors (sustained shakiness of the extremities or jaw) suggest
potential deficits in the development of autonomic nervous systems, the portion of the
nervous system that control unconscious bodily functions such as reflexes, breathing and
heartbeat (Brazelton & Nugent, 2011). Fried (1980) reported that 55% of the infants born
to heavy users exhibited marked startles while only 14% born to non-users exhibited
marked startles (p = 0.023). Similarly, 73% of the infants born to heavy marijuana using
mothers were observed to tremor while only 33% of the infants born to non-users
tremored (p = 0.008; Fried, 1980). In a later study using multiple regression analysis,
Fried and Makin (1987) reported heightened startles (F = 12.89, p < 0.001) and tremors
(F = 3.90; p = 0.05) among prenatal marijuana exposed neonates compared to infants that
were not exposed after controlling for a number of other variables.
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A modification of the NBAS, the NICU Neonatal Neurobehavioral Scale
(NNNS), was developed for the Maternal Lifestyle Study to enhance the detection of
neurobehavioral deficits associated with maternal substance use (Lester et al., 2002). The
results are summarized into 13 scales in which two of them were seen to be abnormal for
marijuana exposed newborns compared to unexposed newborns (Lester et al., 2002).
Lester et al. (2002) reported that the heavy use group newborns demonstrated higher
excitability than unexposed neonates (P = 0.043). A much smaller Brazilian study,
focused on marijuana exposure, showed similar findings with excitability scores of 3.27 ±
1.40 and 2.40 ± 1.57 for marijuana exposed newborns compared to unexposed newborns
(P = 0.006; de Moraes Barros et al., 2006). The de Moraes Barros et al. (2006) study also
found significant differences of arousal (4.05 ± 0.60 and 3.68 ± 0.70; P = 0.009) and
regulation (5.75 ± 0.62 6.04 ± 0.72; P =0.048) scores for exposed and unexposed
neonates, respectively.
The newborn’s cry is a complex combination of the use of several anatomical
features (chest, neck, pharynx, and larynx) where damage or abnormal development of
specific elements of the central nervous system (vagal complex, selected cranial nerves,
phrenic nerves, or thoracic nerves) may affect the acoustic quality of the cry (Lester &
Dreher, 1989). The neurological integrity of the neonate may be predicted by the
duration, pitch, and resonance qualities of the cry (Lester & Dreher, 1989). The duration
is the average time of a cry when stimulated. Percent dysphonation is the percentage of
time a cry includes inharmonic frequencies which is a proxy for turbulence in the cry.
The fundamental frequency (f0) is the perceived voice pitch which is partly determined
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by the vocal fold tension. In their study that compared 20 prenatally marijuana exposed
Jamaican newborns to 20 unexposed Jamaican newborns, Lester and Dreher (1989) found
that the cries were shorter in duration (29.85 sec ± 13.67 sec and 43.15 sec ± 20.05 sec,
respectively), higher percent dysphonation (24.45 ± 15.52 and 5.05 ± 4.68, respectively),
and a higher f0 resonance (457.50 ± 90.15 and 405.50 ± 50.44, respectively) for the
exposed neonates. The Maternal Lifestyle Study found that heavy prenatal marijuana
exposure was associated with increased mode changes (transitions between phonation
and dysphonation; P = 0.010) and increase second formant (second harmonic frequency;
P = 0.005; Lester et al., 2002). Additionally, Fried (1980) noted the association between
prenatal marijuana exposure and “cri de chat”, a distinct cat-like cry usually observed for
infants experiencing withdrawal, but unfortunately, this observation was not expected and
was not objectively measured.
Another measure used for the evaluation of the neonate’s central nervous system
development is the electroencephalogram (EEG) sleep patterns (Scher et al., 1988).
Scher et al. (1988) noted that abnormal EEG patterns during sleep may be predictive of
negative outcomes that are not yet observable. Following detailed maternal interviews,
Scher and colleagues monitored the neonates for a 2-2.5 hour period using EEG during
the first 2 days of life. Their findings included significant differences between unexposed
and exposed neonates including lower total active sleep (46.2% and 38.0%, respectively),
increased small body movement (0.02 movements/minute and 0.2 movements/minute,
respectively), increased large body movement (0.2 movements/minute and 0.6
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movements/minute, respectively), and reduced Rapid Eye Movement sleep (REM; 4.6
per minute and 2.5 per minute, respectively; Scher et al., 1988).
The evidence presented here consistently demonstrated the subtle effects of
prenatal marijuana exposure. The observations reported here pose no immediate physical
deficit or harm to the neonate but are symptomatic of subtle neurobehavioral deficits that
may present as noticeable executive functioning deficits later in life (Fried & Smith,
2001). However, with any research involving maternal substance use, the findings are
limited due to misclassification as a result of reliance on maternal self-report.
Prenatal Marijuana Exposure and Neurobehavioral Deficits of the Preschooler
My search identified seven studies that evaluated the associated neurobehavioral
deficits of preschoolers with prenatal marijuana exposure. The MHPCD study,
conducted at the University of Pittsburgh, followed up with their cohort at age 3 using the
Stanford-Binet Intelligence Scale (Day et al., 1994), a sleep monitoring study (Dahl et al.,
1995), and a gross motor assessment study (Chandler et al., 1996). Noland et al. (2003,
2005) evaluated a 4-year old group focusing on executive function deficits. Leech et al.
(1999) continued with the Pittsburgh cohort at age 6 with an evaluation of their attention
and impulsivity. Fried et al. (1992) reported their findings in their 6-year old Canadian
cohort using McCarthy Scales of Children’s Abilities and the Peabody Picture
Vocabulary test.
To investigate potential neurobehavioral teratogenic effects of prenatal marijuana
exposure, Day et al. (1994) conducted a follow up study of their 655 children from the
MHPCD study in Pittsburgh. The Stanford-Binet Intelligence Scale, an intelligence and
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cognitive ability test designed to evaluate young children for developmental deficits,
measured the cognitive development differences between 3 year old children who were
prenatally exposed to marijuana and children who were not exposed. When comparing
the two groups using the entire composite score, Day et al. (1994) reported no observable
differences. However, regression analysis revealed, while controlling for other substance
use, a significant short term memory deficit (a single test item of the scale) among the
second trimester marijuana exposed children (β = -1.5, P = 0.05; Day et al., 1994).
From this same cohort, Dahl et al. (1995) selected eighteen 3 year old children
from the marijuana exposed group and 20 unexposed children as controls. These children
were subjected to sleep studies to discover any sleep variable differences among the two
groups (Dahl et al., 1995). The children that were exposed to marijuana in utero showed
lower sleep efficiency (exposed = 91.0 ± 3.8; unexposed = 94.4 ± 2.1; P < 0.05) which
was the percentage of recorded sleep study time spent asleep, more awake time following
sleep onset (exposed = 27.4 min. ± 20.0 min.; unexposed = 13.7 min. ± 12.4 min.; P <
0.05) and a higher number of arousals during sleep (exposed = 8.2 ± 5.3; unexposed = 3.2
± 4.6; P < 0.005).
Chandler et al. (1996) designed a gross motor skills assessment for the MHPCD
cohort that was appropriate for evaluating the motor skills of 3 year old children which
included balance (walking on a line, balance beam, and standing on tip toes) and
coordination tasks (ball handling such as catching, throwing, and kicking). Each
completed task performed was scored along with notations showing if the child refused to
perform the requested task (Chandler et al., 1996). No reported observable difference of
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balance or coordination scores between the exposed and unexposed children that
cooperated with the task instructions were observed (Chandler et al., 1996). However,
they did observe, using Rasch Analysis, a correlation of refusal to perform tasks for those
exposed to marijuana in the first trimester (balance task refusal, 0.07, P < 0.05) and
second trimester (balance task refusal, 0.10, P < 0.05; ball handling task refusal, 0.07, P
< 0.05) of gestation. Refusal to perform an activity is not a usual variable of study but in
this instance it may have reflected reluctance, lack of motivation, or fear of anticipated
failure.
Noland et al. (2003) followed a similar cohort of 316 children in Cleveland, OH
which evaluated associations between executive function deficits at age 4 years and
prenatal exposure to various substances of abuse including marijuana (Noland et al.,
2003). Noland and colleagues measured executive function using a tapping inhibition
test (where the child must tap a certain number of times on cue from the tester), a
category fluency test (where the child provides exemplars of categories provided by the
tester such as the color “red”) and a motor planning task test (where the child touches his
thumb to various fingers in sequence following the cue of the tester; Noland et al., 2003).
Although significant differences existed between children exposed prenatally to alcohol
and unexposed children, Noland et al. (2003) were not able to observe any differences for
children exposed prenatally to marijuana compared to those who were unexposed. They
suggested that the skills being challenged by these tests were not yet fully developed for
4 year olds such that there was no opportunity to observe a difference or that the tests
being used were lacking appropriate sensitivity (Noland et al., 2003).
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Noland and colleagues evaluated the same cohort of Cleveland children for
selective attention deficits using two tests, the continuous performance task and a picture
deletion task (Noland et al., 2005). The continuous performance task requires that the
child respond to a target line picture that is randomly displayed amongst a group of other
pictures that are shown in rapid order. The picture deletion task was a timed test where
the child must pick 30 target pictures that are depicted in a group of 120 pictures. Errors
of omission (failed to identify the picture correctly) and commission (picked the wrong
picture) were noted. Regression analysis revealed that children exposed to marijuana in
the first trimester were significantly more inclined to have errors of omission (β = 0.32, P
= 0.03; Noland et al., 2005).
In Ottawa, Canada, Fried et al. (1992) reported that there were no reportable
differences between 5 and 6 year old prenatally exposed children and unexposed controls
using the McCarthy Scales of Children’s Abilities and the Peabody Picture Vocabulary
tests (two validated instruments that measure cognitive performance) suggesting that any
differences previously observed in the Ottawa study had self-corrected. The MHPCD
study in Pittsburgh found differences in attention and impulsivity in a follow up study of
their cohort at 6 years of age. Using the continuous performance tests, like that used in
the previously discussed Cleveland study, Leech et al. (1999) using regression analysis
controlling for other substance use, found that 6 year old children who were exposed to
marijuana in utero had an increase of commission errors (R2 = 0.149, β = 1.21, P < 0.01)
when compared to those who were not exposed.
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These studies reinforce the previously discussed neonatal neurobehavioral studies
prediction of prenatal marijuana exposure being responsible for central nervous system
developmental deficits during specific times of fetal development (Fried, 1996). These
deficits are responsible for subtle effects latter in the life of the child (Fried, 1996). The
studies reported here are limited in that with the exception of the Cleveland study, they
relied on maternal self-report to categorize prenatal substance exposure (Noland et al.,
2003). The deficits observed here with the 3-6 year old children are important because it
is during this time that children are preparing to embark on their primary education
activities where deficits of executive function place them at a distinct disadvantage that
may influence their life trajectory (Fried, 1996).
Prenatal Marijuana Exposure and Adolescent Deficits
The search identified 13 manuscripts from 3 longitudinal studies that reviewed
prenatal marijuana exposure and deficits in adolescents. The Ottawa Prenatal Prospective
Study (OPPS) (4 of the 13 papers) from Canada examined a cohort of low-risk, middle
class newborns following the effects associated with prenatal marijuana, alcohol, and
tobacco exposure. The Maternal Health Practices and Child Development Study in
Pittsburgh, PA (8 of the 13 papers) prospectively followed a large cohort of high-risk
children (n = 763) that examined the effects associated with prenatal exposure to
marijuana and other substances of abuse. One manuscript originated from the Avon
Longitudinal Study of Parents and Children in the United Kingdom, which followed
6,356 children and is the only manuscript from a large prospective study examining the
effects of prenatal marijuana exposure (Zammit et al., 2009).
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Deficits of attention and control of impulsivity continue into adolescence
(O’Connell & Fried, 1991; Fried, Watkinson, & Gray, 1998; Fried & Watkinson, 2001;
Richardson, Ryan, & Williford, 2002). Fried and Watkinson (2001) evaluated the
potential impact of prenatal marijuana exposure on the attention of 13-16 years olds from
the OPPS study using tools developed to explore a multifaceted concept of attention,
which are focus/execute, shift/flexibility, arouse/exert, encode/retain, and stability.
Seven tests for attention evaluation used for this study were the Continuous Performance
Test, the Wisconsin Card Sorting Test, the Stroop Test, and the Wechsler Intelligence
Scale for Children Arithmetic Test, Sentence Memory Test, Seashore Test, and Knox
Cube Test. The primary finding of this study was that stability, one’s ability to maintain
attention over time, was negatively affected by prenatal marijuana exposure (F = 5.1, P <
0.01; Fried & Watkinson, 2001). Previous reports from this research group (O’Connell &
Fried, 1991; Fried et al., 1998) also indicated potential attention deficits due to prenatal
marijuana exposure at ages 9-12 but those reports noted that the differences were not
statistically significant, perhaps due to the use of smaller sub-cohorts or the higher
socioeconomic level of the cohort. The MHPCD cohort, at age 10, demonstrated an
increase of errors of commission for the Continuous Performance Test, an Attention Task
Test, which suggests that the participant has issues with impulse control (β = -1.86, R2 =
0.01; Richardson et al., 2002).
The issues of attention deficit and impulse control lead to a natural consequence
of poor academic performance for the prenatal marijuana exposed children.
Goldschmidt, Richardson, Cornelius and Day (2004) reported that 10 year olds who were
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exposed to marijuana in utero exhibited specific deficits with academic development.
The MHPCD researchers tested their cohort at age 10 using the Wide Range
Achievement Test-Revised, the Peabody Individual Achievement Test, and a report from
their school teacher ranking their performance in various subjects (Goldschmidt et al.,
2004). Heavy prenatal marijuana exposure in the first trimester was associated with
decreased reading scores (β = -3, P < 0.05), decreased spelling scores (β = 3.5, P < 0.05)
and lower ratings from their teachers (β = 0.25, P < 0.05; Goldschmidt et al., 2004).
Fried, Watkinson, and Siegel (1997) also observed lower reading and language scores for
their 9 and 12 year olds in the OPPS study but again this could be attributed to an
insufficient number of participants; the differences were statistically insignificant.
The MCPCD study evaluated a cohort of prenatal marijuana exposed children for
depressive symptoms at age 10 (Gray, Day, Leech, & Richardson, 2005). Using the
Children’s Depression Inventory (a validated instrument for detecting depressive
symptoms), Gray et al. (2005) reported that more children that were exposed to marijuana
in the first trimester and third trimester exhibited depressive symptoms (β = 1.83 and
2.58, respectively) and both findings were statistically significant (P < 0.01). On a
similar mental health evaluation of marijuana exposed children, Zammit et al. (2009),
using the Avon Longitudinal Study of Parents and Children, demonstrated no association
of prenatal marijuana exposure with psychotic symptoms.
Another concern for adolescents with demonstrated neurobehavioral deficits is the
presence of delinquent behaviors. The MCPCD study examined the potential relationship
between prenatal marijuana exposure and delinquent behaviors at ages 10 and 14
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(Goldschmidt, Day, & Richardson, 2000; Day, Leech, & Goldschmidt, 2011). Using the
Swanson, Noland, and Pelham (SNAP) Test, Goldschmidt et al. (2000) found that
children exposed to increasing levels of marijuana (none, light, moderate, and heavy) in
the third trimester, exhibited higher scores for hyperactivity and impulsivity (F = 5.4, P <
0.005 and F = 4.4, P < 0.01, respectively). As would be expected from a child with
hyperactive and impulse control issues, children exposed to marijuana in utero were 2.4
times higher risk (95% CI: 1.3, 4.5; P < 0.01) of being identified as a delinquent using the
Teacher Report Form when compared to children not exposed (Goldschmidt et al., 2000).
This trend continued for this cohort at age 14 using the Self-Report Delinquency Scale
and the Child Behavior Checklist (Day, Leech, & Goldschmidt, 2011) where the exposed
group were 1.84 times higher odds ratio (95% CI: 1.05, 2.96; P = 0.03) to be categorized
as possessing delinquent behavior than those children who were not exposed.
These concerns lead into the final element of evidence supporting the negative
consequences of prenatal marijuana exposure, which can lead to increased marijuana use
among adolescents (Day, Goldschmidt, & Thomas, 2006). Using the Cox Proportional
Hazards Strategy, Day and colleagues (2006) demonstrated that each additional average
daily joint of maternal marijuana use was associated with a 1.14 increase (P = 0.04) in the
hazard ratio for marijuana use at age 14. An elevated level of marijuana use continues
through to young adulthood with the offspring of marijuana users having 1.22 times
higher odds ratio (95% CI: 1.02, 1.44; P = 0.019) to use marijuana than offspring of
nonusers. These users are of reproductive age, and their prior prenatal exposure and
potential current use of marijuana sets the stage to expose the next generation to the
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negative consequences of prenatal marijuana exposure (Sonon, Richardson, Cornelius,
Kim, & Day, 2015).
Again, these studies are limited because category selection is based on maternal
self-report and cohort size and selections are not necessarily generalizable. However,
these children continue to demonstrate statistically significant issues with attention and
impulsivity disorders. These deficits appear to manifest themselves in academic
underachievement and depressive symptoms. Lastly, children, prenatally exposed to
marijuana, tend to gravitate toward marijuana usage in adolescents and early adulthood
(reproductive age), increasing their risk for repeating this negative cycle.
Theoretical Foundation
The Theory of Planned Behavior and Maternal Marijuana Usage
Attempting to define predictors and explanations to describe human behavior is at
best an extremely complicated task. One theory that has emerged as a leading tool in the
study of predicting human behavior in the field of addiction is the theory of planned
behavior (Ajzen, 1991). As an extension of the theory of reasoned action, the principle
element of the theory is that an individual must exhibit intention to perform a particular
behavior, and that the behavior will only be performed when sufficient intention is
present (Ajzen, 1991). The theory of reasoned action states that two factors, attitude and
subjective norms toward the behavior, influence an individual’s intention.
Attitudes toward a behavior are the beliefs of the individual toward performing a
behavior (Ajzen, 1991). Does the individual have a favorable or an unfavorable attitude
toward performing a behavior? For example, does the pregnant mother think that
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smoking marijuana is harmful or harmless for herself or her unborn child? Does the
individual think getting high feels good? Does the individual think that smoking
marijuana improves their image? Although individual attitude is an important element,
the environment in which the behavior is performed is just as important.
Subjective norm refers to an individual’s concept of the social acceptability or
opinion if a behavior is performed (Ajzen, 1991). What would my partner think of me if I
smoke marijuana? Would my parents, colleagues, pastor, or neighbors have a favorable
opinion of me if I smoke marijuana? Does my state of residence condone possession and
usage of marijuana? Attitude and subjective norm are significant variables that influence
intention to perform a behavior, however, Ajzen (1991) found that this model had
limitations and proposed a third equally important factor which evolved the theory of
reasoned action into the theory of planned behavior.
Perceived behavioral control focuses on the concept that the individual’s
perception of how much control they have over performing a behavior influences
intention (Ajzen, 1991). Does the individual have control over the using marijuana?
Does the individual perceive that they have control of a drug craving? Does the
individual perceive that they have access to marijuana and money to purchase marijuana?
Does the individual perceive that they can obtain marijuana without legal conflict? These
three factors, attitude, subjective norm, and perceived behavioral control, combine to
form an individual’s intention to perform a behavior and they may be used to predict a
behavior (Ajzen, 1991).
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Studies of the Association of Medical Marijuana and Use
Marijuana continues to be the most used illicit substance in the United States
therefore the downstream consequences of changes in marijuana laws or policies may
potentially impose a significant public health impact. It is important to understand the
influence of marijuana law changes on use and abuse among the general public and even
more important to understand its influences on vulnerable groups such as adolescents and
pregnant women as well. The association of the approval of medical marijuana laws,
higher rates of marijuana use, and lower perceived risk of use in adult populations exists
but fortunately, this trend was not observed for adolescents. Additionally, in the
environment of a freer market to operate, growers have dramatically improved the
potency of marijuana.
Medical Marijuana Laws and Increased Use
Two national surveys, the National Epidemiologic Survey on Alcohol and Related
Conditions (NESARC) and the National Survey on Drug Use and Health (NSDUH),
examined the evidence of the influence of state level marijuana policy on marijuana use
(Cerda et al., 2012). An evaluation of the two surveys by Cerda and colleagues (2012)
showed significant increases in past year marijuana use among respondents living in
states with medical marijuana laws (OR = 1.92; 95% CI: 1.49, 2.47). Their study was
based on a simple variable of the allowance of medical marijuana by year 2004 and was
limited in the inability to demonstrate causality. Pacula and colleagues (2015) also
investigated whether marijuana use was increased in states that passed new laws using
data from the Treatment Episodes Data System (TEDS) and the National Longitudinal
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Survey of Youth (NLSY97). Pacula and colleagues (2015) noted that statewide
marijuana policy is not homogeneous but is a complex variable including such elements
as mandatory registries, allowance of home cultivation, and provision of commercial
dispensaries. Further complicating the examination is a time lag between implementation
of the law and measurement of use, allowing for various elements to be missed or
misrepresented (Pacula et al., 2015). Presence of legally operating dispensaries was a
significant predictor (β = 0.204 ± 0.069, P < 0.01) of increased marijuana use according
to treatment admissions (Pacula et al., 2015). These studies evaluated observations made
on use of marijuana in the general public and did not address specific vulnerable groups.
Medical Marijuana Laws and Increased Adolescent Use
A group considered to be at higher risk when modifying marijuana law and policy
are adolescents. This group is at a developmental stage where neurobehavioral
development is still ongoing, the risk for developing negative health behaviors is higher,
and in the context of this manuscript they represent a population entering the age of
reproduction (Wall, Poh, Cerda, Keyes, Galea, & Hasin, 2011). Wall and colleagues
conducted a simple review of the prevalence of marijuana use among adolescent
respondents to the NSDUH between 2002 and 2008. Their findings showed that
adolescent marijuana use was higher in adolescents living in states that allowed medical
marijuana than use among those who lived in states that did not allow medical marijuana
(8.68%, 95% CI: 7.95%, 9.42% and 6.94%, 95% CI: 6.60%, 7.28%, respectively).
Equally troublesome was the observation that fewer adolescents living in states that
allowed medical marijuana perceived marijuana use as health risk than adolescents that
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lived in states that did not allow medical marijuana (30.5% and 35.7%, respectively; Wall
et al., 2011). Wall et al. (2011) noted that this study was limited in that causation was not
demonstrated because there are many different elements to marijuana policy and the
policy may simply reflect an already present pro-marijuana population (Wall et al.,
2011).
The following year, another study attempted to replicate these findings using the
same databases but used a more complex difference in differences regression approach in
an attempt to demonstrate evidence of causation (Harper, Strumpf, & Kaufman, 2012).
Similar to Wall et al. (2011), Harper et al. (2012) observed an increase of adolescent
marijuana usage of nearly 2% (β = 1.87, 95% CI: 1.5, 2.2) when fixing year effects to
overall secular trends of marijuana use, but when the difference in differences approach
included a fixed effect by state trend, they observed a slight decrease in adolescent
marijuana use (β = -0.59, 95% CI: -1.1, -0.1). Using a similar approach with data from
the Youth Risk Behavior Survey (YRBS), Lynne-Landsman, Livingston, and Wagenaar
(2013) found no evidence of medical marijuana law causation of increased adolescent
marijuana use when comparing four states with medical marijuana laws against each
other before and after marijuana law adoption. Choo, Benz, Zaller, Warren, Rising, and
McConnell (2014) compared states that allowed medical marijuana to a proximal state
that does not allow medical marijuana and did not observe any association with increased
adolescent marijuana use. The 95% confidence interval for all comparisons included
zero which implies an insignificant observation. According to these approaches, there
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was a lack of evidence that the adoption of more relaxed statewide marijuana policies
caused an increase in adolescent marijuana use.
Current Trends of Marijuana Potency
Cannabis refers to the plant Cannbis sativa L which has been used recreationally,
medicinally, and for religious ceremonies by humans for thousands of years (ElSohly &
Gul, 2014). The term cannabinoids refers to compounds unique to Cannabis sativa as
well as all of their derivatives and metabolites (biotransformation products) (ElSohly &
Gul, 2014). At this time there are 545 cannabinoids defined and described in the
scientific literature (ElSohly & Gul, 2014). Phytocannabinoids refer specifically to the
compounds that originate from the plant itself and currently there are 104
phytocannabinoids defined and described in the literature (ElSohly & Gul, 2014). The
principle psychoactive phytocannabinoid is (-)-∆9-tetrahydrocannabinol (∆9-THC;
ElSohly & Gul, 2014).
The National Institute on Drug Abuse (NIDA) maintains a contract with the
University of Mississippi to cultivate marijuana for research purposes and to operate the
Potency Monitoring Program (Mehmedic et al., 2010). This program analyzes cannabis
seizures from around the country for the purpose of monitoring the product being
distributed over time (Mehmedic et al., 2010). The program analyzed thousands of
samples from seized contraband annually for a number of phytocannabinoids, including
∆9-THC (Mehmedic et al., 2010). The results from these analyses are periodically
cumulated and reported in forensic literature (Mehmedic et al., 2010).
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The most recent Potency Monitoring Program report states that the potency of
cannabis (dry weight percentage of ∆9-THC) has been steadily increasing (ElSohly et al.,
2016). In the 1990’s, cannabis typically contained 3-4% ∆9-THC whereas the most
recent average seizures contain 11-12% ∆9-THC (ElSohly et al., 2016). From 1995 to
2014, the proportion of contraband samples that contained an excess of 12% ∆9-THC has
risen sharply (0.64% to 41.22%), while the proportion of contraband samples that
contained < 3% ∆9-THC has dropped dramatically (28.43% to 7.73), further illustrating
the improvement of the quality of illicit cannabis available to the public (ElSohly et al.,
2016).
This alarming trend of increased marijuana potency has stimulated concerns in
many different fields of substance use and abuse. Sevigny et al. (2014) demonstrated that
potency has increased in association with adoption of laws allowing medical marijuana.
Concern has also been raised about the effects of stronger marijuana from a perspective
of its unintended influences on drugged driving, drug-induced psychoses, and adolescent
use (Sevigny et al., 2014). Regardless of causation or association, the potency of
marijuana has dramatically increased over the past two decades and the impact of that
increase raises public health concerns in many areas of study.
Summary
Marijuana is the most prevalent illicit drug used in the United States, however
perceptions of its harmfulness has been declining. Often thought of as harmless, this
literature review demonstrated that maternal marijuana use is associated with a number of
neurobehavioral deficits that initiate a cascade of deficits for the remainder of the
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exposed newborn’s life. Newborns exposed to marijuana exhibit abnormal tremors and
startles as well has abnormal sleep behaviors which is consistent with an under lying
neurological abnormalities to be expressed later in life. Marijuana exposed newborns
demonstrate lower academic achievement and increased behavioral problems during their
preschool and adolescent years and finally culminate in an increased odds ratio for
adolescent drug initiation early on in their reproductive ages. This completes a repetitive
cycle of deficit.
With the knowledge of the negative consequences of maternal marijuana use,
policymakers must be aware of the unintended consequences of statewide marijuana
policy relaxation. Policy allowing for the cultivation and commercialization of marijuana
influences perceived behavioral control by making marijuana more easily obtainable in
the community without fear of negative legal consequences. Marijuana cultivators
operating in a free market atmosphere are producing product with dramatically higher
concentrations of THC. The adoption of medical marijuana laws with the implication
that marijuana as medicine must be good for you, may influence social norms to lower
the perceived risk of marijuana use among pregnant women. Over time, as the social
norms evolve and perceived behavioral control increase, so too will attitudes toward use,
as has been demonstrated with young adults. Using the theory of planned behavior as a
theoretical foundation, the effect of statewide marijuana policy relaxation on attitude,
social norms, and perceived behavioral control are key factors that increase intent to use
marijuana which in turn leads to increased use of marijuana as predicted by the theory.
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Studies of the influence of statewide marijuana policy relaxation on the general
population, and specifically on adolescents, exist, but studies are lacking when it comes
to the evaluation of prenatal marijuana use. This work is important because the negative
health consequences of marijuana use are not only confined to the user, but these
consequences are also transferred to the unborn baby whose quality of life may be
diminished through the action of another. This study will attempt to evaluate the
influence of statewide marijuana policy relaxation on pregnant women by comparing the
prevalence and frequency of use of marijuana by pregnant women living in states with
varying levels of marijuana control. Understanding the unintended negative
consequences of statewide marijuana policy relaxation will allow policymakers to
consider specific exemptions for vulnerable population and allow public health
professionals to better design and implement appropriate interventions.
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Chapter 3: Research Method
The purpose of this quantitative secondary analysis was to evaluate a potential
association between statewide medical marijuana policy and maternal marijuana usage.
This section explores the research design and rationale, methodology, including a
description of the population, the sampling design, data collection, and the plan to
analyze the data. The section ends with a discussion of the threats to the validity of the
study, calculation of the required sample size, and a discussion of ethical concerns.
Research Design and Rationale
The outcome or dependent variables for this study were maternal use of marijuana
and the amount of self-reported maternal marijuana use. Two questions from the
National Survey of Drug Use and Health (NSDUH) that were used for this study are,
“How long has it been since you last used marijuana or hashish?” and “On how many
days in the past year did you use marijuana or hashish?” NSDUH, creating a
dichotomous dependent variable, defined maternal marijuana use as a woman who was
aware of pregnancy, reporting the use of marijuana within the past month or year. The
amount of maternal marijuana use was defined by the response to the question, “On how
many days in the past month did you use marijuana or hashish?” Answers were recoded
into categories of light and heavy for ease of analysis. Light use was defined as less than
100 days and heavy use was equal to or more than 100 days of use.
The independent variable for this study was the dichotomous entry of a variable
which reflected the approval of medical marijuana in the state of primary residence of the
respondent. States were categorized according to medical marijuana law policy effective
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at the time the study was conducted. The categories were medical marijuana use
permitted and medical marijuana not permitted. Covariates used for further evaluation
were age, race/ethnicity, education level, household income, and marital status.
Using the responses from the NSDUH, comparisons were made between the
prevalence and the amount of self-reported maternal marijuana use between the two
categories of statewide medical marijuana policy in a particular time period. A crosssectional quantitative study design was used to evaluate these findings. In Chapter 2,
reviews of several cross-sectional quantitative studies that used national databases to
evaluate potential factors of substance use were assessed (Muhuri & Gfoerer, 2008;
Saurel-Cubizolles et al., 2014; Ko et al., 2015).
Methodology
Population
The NSDUH is a nationwide survey conducted periodically by the Center for
Behavioral Health Statistics and Quality (CBHSQ), a department within SAMHSA, for
the purpose of providing accurate surveillance data of drug use patterns within the United
States (CBHSQ, 2015). The CBHSQ targets respondents ages 12 years and older
residing in civilian, non-institutional, settings (CBHSQ, 2015). The survey did not
include individuals in the military, incarcerated, or homeless not living in shelters.
However, the survey did include civilians living on military installations and homeless
individuals residing in shelters (CBHSQ, 2015). A staff of approximately 700 field
investigators conducted over 67,000 interviews for the 2014 NSDUH (CBHSQ, 2015).
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Sampling
The NSDUH sampling plan used a multidimensional stratification to ensure
adequate representation of the national population. The primary level of stratification
was the state, including the District of Columbia (SBHSQ, 2015). The second layer of
stratification consisted of 750 equally sized state sampling regions (SSR; SBHSQ, 2015).
Census tracts (n = 48) within each SSR were identified, census block groups were
established within each census tract, and area segments selected from the census block
groups were designed to create the third level of stratification (SBHSQ, 2015). A
designated number of dwelling units were selected, depending on state and/or location, to
recruit respondents (SBHSQ, 2015). Lastly, in each dwelling unit, up to two participants
were selected to participate in the survey (SBHSQ, 2015).
Data Collection
Following the identification of the dwelling units, a letter of introduction was
mailed to the dwelling unit informing them that they had been randomly selected to
participate in the NSDUH (SBHSQ, 2015). Trained field interviewers visited the
location, requested to speak to an adult, and conducted a brief interview to obtain basic
demographic information (SBHSQ, 2015). This information was entered into a handheld
computer system that randomly selected between zero and two participants for the survey
from that dwelling unit (SBHSQ, 2015).
The field interviewer and the participant proceeded to a private area within the
dwelling unit to complete the survey using two different information gathering platforms
(SBHSQ, 2015). A computer-assisted personal interview (where the interviewer read
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questions and recorded the responses) and an audio computer-assisted self-interview
(where the survey questions were read from a computer screen or heard by participants
using headphones), and the responses were recorded by the participant on the computer
(SBHSQ, 2015). The results were securely transferred to the study headquarters for
analysis (SBHSQ, 2015). Participants received $30 upon completion of the survey
(SBHSQ, 2015). The data, along with the codebook, are available in the public domain
for download at SAMHSA’s website.
Data Analysis Plan
I used IBM SPSS Statistics (version 23) to perform all calculations. Descriptive
statistics calculations included prevalence of past 30 day and past year self-reported
marijuana use, distribution of past month number of days marijuana use, age categories,
racial/ethnicity distribution, household income distribution, education distribution and
marital status distribution. The frequency and percentage of each descriptive statistic
were reported.
Inferential statistics were calculated to test the following research hypotheses:
Research Question 1: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is not
allowed?
H01: There is no difference between the proportions of pregnant women that
self-report marijuana use during the past 30 days living in states where
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medical marijuana is allowed compared to states where medical marijuana is
not allowed.
Ha1: There is a difference between the proportions of pregnant women that
self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is
not allowed.
Research Question 2: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not allowed?
H02: There is no difference between the proportions of pregnant women that
self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not
allowed.
Ha2: There is a difference between the proportions of pregnant women that
self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not
allowed.
Research Question 3: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is not allowed
while controlling for the covariates age, income, race/ethnicity, educational level, and
marital status?
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H03: There is no difference between the proportions of pregnant women that
self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is
not allowed while controlling for the covariates age, income, race/ethnicity,
educational level, and marital status.
Ha3: There is a difference between the proportions of pregnant women that
self-report marijuana use during the past 30 days living in states where
medical marijuana is allowed compared to states where medical marijuana is
not allowed while controlling for the covariates age, income, race/ethnicity,
educational level, and marital status.
Research Question 4: Are there significant differences in the proportion of pregnant
women that self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not allowed while
controlling for the covariates age, income, race/ethnicity, educational level, and marital
status?
H04: There is no difference between the proportions of pregnant women that
self-report marijuana use during the past year living in states where medical
marijuana is allowed compared to states where medical marijuana is not
allowed while controlling for the covariates age, income, race/ethnicity,
educational level, and marital status.
Ha4: There is a difference between the proportions of pregnant women that
self-report marijuana use during the past year living in states where medical
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marijuana is allowed compared to states where medical marijuana is not
allowed while controlling for the covariates age, income, race/ethnicity,
educational level, and marital status.
Research Question 5: Is there a difference in the prevalence of pregnant women that selfreport heavy marijuana use compared to light marijuana use during the past year for
women living in states that allow medical marijuana use and women living in states that
do not allow medical marijuana use?
H05: The prevalence of pregnant women that report heavy marijuana use
compared to pregnant women that report light marijuana use during the past
year is not different for women living in states that allow medical marijuana
use and women living in states that do not allow medical marijuana use.
Ha5: The prevalence of pregnant women that report heavy marijuana use
compared to pregnant women that report light marijuana use during the past
year is different for women living in states that allow medical marijuana use
and women living in states that do not allow medical marijuana use.
The independent variable for questions 1 and 2 was the category of state medical
marijuana policy, a dichotomous variable. The dependent variables for research question
1 and 2 were the self-reported past 30-day use of marijuana, a dichotomous variable
(yes/no) and the self-reported past year use of marijuana, also a dichotomous variable
(yes/no). The appropriate inferential statistic to test H01 and H02 was Pearson’s χ2 test
(Green and Salkind, 2014). A P-value less than 0.05 allows for the rejection of H01 and
H02 (Green and Salkind, 2014).

54
The independent variable for questions 3 and 4 was, again, the category of state
medical marijuana policy, a dichotomous variable. The dependent variable for research
questions 3 and 4 was the self-reported past 30-day use of marijuana, a dichotomous
variable (yes/no) and the self-reported past year use of marijuana, also a dichotomous
variable (yes/no). The covariates age, income, educational level are ordinal variables and
the covariates race/ethnicity and marital status are nominal variables. The appropriate
inferential statistic to test H03 and H04 was the multiple logistic regression.
The independent variable for questions 5 was the category of state medical
marijuana policy, a dichotomous variable. The dependent variable for research question
5 was the level of self-reported past year use of marijuana, heavy use (≥ 100 days) and
light use (< 100 days). The appropriate inferential statistic to test H05 was Pearson’s χ2
test (Green & Salkind, 2014). A P-value that was less than 0.05 will allow for the
rejection of H05 (Green & Salkind, 2014).
Measures
Pregnant. This study was limited to only pregnant women who successfully
completed the NSDUH in 2014. The variable PREGNANT recorded the participant’s
response to the question, “Are you currently pregnant?” The responses were recorded as
“Yes,” “No,” “Don’t Know,” “Refused,” “Blank,” or “Legitimate Skip.” Only the
respondents with a response of “Yes” were included in this study.
Maternal marijuana use past month. One of the dependent variables of this
study was past month maternal marijuana use as defined using the variable MRJMON,
which was a recoded variable from the response to the question, “How long has it been
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since you last used marijuana or hashish?” The responses recorded from the original
question were, “Within the past 30 days,” “More than 30 days ago but within the past 12
months,” “More than 12 months ago,” “Used at some point within the past 12 months logically assigned,” “Used at some point in the lifetime – logically assigned,” “Used in
the past 30 days – logically assigned,” “Never used marijuana,” “Refused,” and “Blank.”
Responses recorded as “Within the past 30 days” and “Used in the past 30 days –
logically assigned.” From this data, MRJMON was a convenient recode of past month
use recorded as “did not use in the past month” or “did use in the past month.”
Maternal marijuana use past year. Another of the dependent variables of this
study was past year maternal marijuana use as defined using the variable MRJYR, which
was a recoded variable from the response to the question, “How long has it been since
you last used marijuana or hashish?” which was detailed above. From this data, MRJYR
was a convenient recode of past year use recorded as, “Did not use in the past year” or
“Did use in the past year.”
Frequency of use. The variable MRJYDAYS defined frequency of use which
was the response to the question, “During the past year, on how many days did you use
marijuana or hashish?” Responses were recorded into the categories, “1-11 days,” 12-49
days,” 50-99 days,” 100-299 days,” “300-365 days,” or “nonuser or did not use in past
year.” This variable was further aggregated into less than 100 days as light use and 100
or more days as heavy use.
Medical marijuana policy of state of primary residence. The variable
MEDMJST2 defined the medical marijuana policy of the respondent’s state of primary
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residence at the time of the interview. The variable was recorded as either, “In state
where marijuana is approved for medical use before interview” or “Not in state where
marijuana is approved for medical use by interview date.”
Age. The variable PREGAGE2 defined maternal age. This variable was recoded
as “1 = 15-17 years old,” “2 = 18-25 years old,” “3 = 26-44 years old,” and “4 =
Otherwise.”
Race/Ethnicity. The variable NEWRACE2 defined race. The variable was
recorded as “1 = NonHisp White,” “2 = NonHisp Black/Afr Am,” “3 = NonHisp Am/Ak
Native,” “4 = NonHisp Native HI/Other Pac Isl,” “5 = NonHisp Asian,” “6 = NonHisp
more than one race,” and “7 = Hispanic.”
Education level. The variable EDUCCAT2 defined the education level of the
participant. The variable was recorded as “1 = Less than high school,” “2 = High school
graduate,” “3 = Some college,” “4 = College graduate,” and “5 = 12 to 17 years old.”
Household income. The variable INCOME defined the income of the household
that the participant resides in. The variable was recorded as “1 = Less than $20,000,” “2
= $20,000 - $49,999,” “3 = $50,000 - $74,999,” and “5 = $75,000 or More.”
Marital status. The variable IRMARIT defined the marital status of the
respondent. The variable was recorded as “1 = Married,” “2 = Widowed,” “3 = Divorced
or separated,” “4 = Never been married,” and “99 = Legitimate skip respondent less than
14 years old.”
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Threats to Validity
External validity threats included the representativeness of the sample and
reactive arrangements during the execution of the survey (Frankfort-Nachmias &
Nachmias, 2008). The NSDUH mitigated the first of these concerns by the use of a
complex multistage random selection process that randomly picked households across
750 equally distributed state sampling regions. The interviewers conducted the survey at
the respondent’s home, in a private area of the home, and used a private computer or
audio based system to record answers in private. The private de-identified nature of the
survey mitigated the external threat of reactive arrangements.
Threats to internal validity refer to various aspects of a study that unintentionally
affect the outcome of an experiment or survey (Creswell, 2009). The cross-sectional,
non-experimental, and random selection design of the NSDUH survey mitigated a
number of these recognized threats. The cross-sectional design eliminated the threats due
to history, maturation, mortality, and testing. The non-experimental nature of the study
mitigated potential internal threats due to diffusion of treatment, compensatory
demoralization, and compensatory rivalry. Additionally, the multistage random selection
of dwelling units mitigated threats due to regression and selection.
SBHSQ assessed the reliability of the interview process in 2006 by reinterviewing 3,136 respondents 5 to 15 days following the initial interview (SBHSQ,
2015). The assessment compared the responses of the two interviews and calculated
Cohen’s kappa (SBHSQ, 2015). Questions concerning the use of marijuana were very
consistent with kappa values for past year use of 0.82 and lifetime use of 0.93 (SBHSQ,
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2015). Cohen (1960) considered kappa values greater than 0.81 to reflect nearly perfect
agreement.
Statistical conclusion validity refers to the situation where an inappropriate
sample size was used for interpretation of outcomes (Creswell, 2009). The number of
respondents used in a study must be large enough to have sufficient statistical power yet
small enough to be feasible to execute. A power of 0.80 is the commonly accepted level
of sufficient statistical power (Creswell, 2009). To mitigate this potential threat,
calculations were performed to determine the number of respondents required for this
study in the following subsection “Sample size.”
Sample Size
The 2014 NSDUH is considered a large dataset with over 60,000 respondents
recorded. This study evaluated pregnant women, a small subset of the total database,
therefore it was necessary to determine if the number of pregnant women that responded
to the NSDUH provided sufficient power for this analysis. According to Ellis (2010), the
sample size required for a study is related to three variables, the significance criterion
(α), the power (1-β), and the effect size (d).
The significance criterion (α) is a measure of the Type I error which represents
the probability of incorrectly rejecting a true null hypothesis and the commonly desired
level of α is 0.05 (Ellis, 2010). Type II error (β), the probability of accepting a false null
hypothesis, is related to the power (1-β) and the commonly desired power is 0.80 (Ellis,
2010). The effect size represents the strength of an observation and the value used for a
prospective sample size analysis is grounded by the observed effect sizes of related
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studies (Ellis, 2010). Based on the work of Cerda et al. (2012) and Pacula et al. (2015), I
chose a small effect size of 0.1 for this calculation.
Estimates were calculated using G*Power 3.1.9.2 software. The Test Family
selection was “z tests” and the Statistical Test selected was “logistic regression.” The
effect size (odds ratio = 1.3), the desired α error probability (0.05), the desired power
(0.80), and the number of categories (3) was entered in the software form. The program
estimated that 557 respondents were necessary for the study.
Ethical Procedures
All participants provided informed consent following protocols approved by
Research Triangle Institute’s Institutional Review Board (IRB; RTI, 2013). Survey
personnel captured the data in a confidential manner and transmitted the data securely to
the NSDUH study headquarters (RTI, 2013). De-identified data is available to the public
through internet download for secondary data analysis without further IRB approval.
All of the data used for this study was anonymous. Although the de-identified
secondary data is freely available to the public, Walden University IRB approval was
required for this study. Walden University IRB granted approval on October 27, 2016
with approval number 10-27-16-0262348.
Summary
In this chapter, I provided a detailed discussion of the research design and
methodology used in this quantitative secondary analysis of the 2014 NSDUH survey.
The variables used in this study were defined and operationalized. The plan of data
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analysis and a priori sample size calculation were described. Lastly, the threats to the
validity of the study and the ethical procedures were discussed.
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Chapter 4: Results
Introduction
The purpose of this study was to evaluate the association of state medical
marijuana laws and maternal marijuana use. Marijuana has been classified as a teratogen
and prenatal marijuana exposure has been linked to a number of neurobehavioral deficits.
The study compared the responses of pregnant women from a large national survey
regarding their marijuana consumption during the past 30 days and past year. The
pregnant women were categorized into two groups, those residing in states that allow
medical marijuana and those residing in states that do not allow medical marijuana at the
time of interview.
Five research questions were used to evaluate the association of state medical
marijuana laws and maternal marijuana use. The first research question asked if there
were significant differences in the proportion of pregnant women that self-report
marijuana use during the past 30 days living in states where medical marijuana was
allowed compared to states where medical marijuana was not allowed. The second
research question asked if there were significant differences in the proportion of pregnant
women that self-report marijuana use during the past year living in states where medical
marijuana was allowed compared to states where medical marijuana was not allowed.
The third and fourth research questions were follow up questions to research questions 1
and 2 that control for age, income, education, race/ethnicity, and marital status. Research
question 5 asked if there was a difference in the level (light use versus heavy use) of past
year marijuana use for pregnant women where medical marijuana was allowed compared
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to states where medical marijuana was not allowed. The theory of planned behavior
suggests that the increased subjective norm and perceived behavioral control associated
with a jurisdiction that allows medical marijuana use would increase the intention of an
individual to use marijuana leading to increased use in the population.
This study utilized the 2014 National Survey on Drug Use and Health (NSDUH).
This chapter will provide details concerning the collection of the data, descriptive
statistics of the respondents, and inferential statistics of their responses to the survey
questions used to answer the research questions summarized above. Lastly, a summary
of the results section will conclude the chapter.
Data Collection
This study did not require any direct contact with any of the survey participants.
This project was a secondary analysis of the 2014 NSDUH which is a de-identified
dataset available for public use. Following approval by the Walden University
Institutional Review Board (IRB approval number 10-27-16-0262348) and registration
with the Interuniversity Consortium for Political and Social Research (ICPSR), the 2014
data were imported into Statistical Package for the Social Sciences (SPSS, version 23).
The 2014 NSDUH dataset contained responses from 55,271 participants. A selection was
performed to only include women that responded in the affirmative to the question, “Are
you currently pregnant” (N = 758). The age range of the self-reported pregnant
respondents was 14-44 years of age. There were no discrepancies from the plan
described in Chapter 3.
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Descriptive Statistics
Of the 55,271 randomly selected respondents that participated in the 2014
NSDUH, 758 reported that they were pregnant at the time of interview. There were 3
(0.4%) individuals that were 14 years old, 20 (2.6%) in the 15-17 year old age group, 390
(51.5%) in the 18-25 year old age group, and 345 (45.5%) in the 26-44 year old age
group. The family annual income distribution was 210 (27.7%) with family income less
than $20,000, 244 (32.2%) between $20,000 and $49,999, 124 (16.4%) between $50,000
and $74,999, and 180 (23.7%) over $75,000. The respondents reported that 117 (15.4%)
did not finish high school, 215 (28.4%) completed high school, 190 (25.1%) obtained
some college, and 213 (28.1%) completed college. The race/ethnicity distribution was
414 (54.6%) non-Hispanic White, 108 (14.2%) non-Hispanic Black, 20 (2.6%) Native
American/Alaska Native, 10 (1.3%) Hawaiian/Pacific Islander, 34 (4.5%) Asian, 25
(3.3%) multiracial, and 147 (19.4%) Hispanics. There were 391 (51.6%) married
respondents, 43 (5.7%) divorced/separated, and 321 (42.3%) never married. At the time
of interview, 306 (40.4%) respondents lived in a state that allowed medical marijuana
while 452 (59.6%) did not. These results are listed in Table 2.
An overview of the prevalence and frequency of maternal marijuana use appears
in Table 3. The survey revealed 48 (6.3%) pregnant women self-reported marijuana use
within the past 30 days and 122 (16.1%) pregnant women self-reported marijuana use
during the past year. The survey showed that 636 (83.9%) of the pregnant women did not
use any marijuana during the previous year while 30 (4.0%) used 1-11 days, 22 (2.9%)
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used 12-49 days, 16 (2.1%) used 50-99 days, 41 (5.4%) used 100-299 days, and 13
(1.7%) used 300-365 days during the past 12 months.
Table 2
Core Demographic Frequencies and Percentages of Pregnant Women Respondents of the
2014 NSDUH (N = 758)

Age Group
15-17
18-25
26-44
Otherwise
Family Income
Less than $20,000
$20,000-$49,999
$50,000 - $74,999
$75,000 or more
Education Level
Did not finish high school
High School Graduate
Some College
College Graduate
Race Ethnicity
Non-Hispanic White
Non-Hispanic Black
Non-Hispanic Native Am/AK
Non-Hispanic HI/Other Pac Island
Non-Hispanic Asian
Multiracial
Hispanic
Marital Status
Married
Divorced/Separated
Never Married
State Marijuana Law Status
Medical Marijuana Allowed
Medical Marijuana Not Allowed

n

%

20
390
345
3

2.6
51.5
45.5
0.4

210
244
124
180

27.7
32.2
16.4
23.7

117
215
190
213

15.4
28.4
25.1
28.1

414
108
20
10
34
25
147

54.6
14.2
2.6
1.3
4.5
3.3
19.4

391
43
321

51.6
5.7
42.3

306
452

40.4
59.6
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Table 3
Frequencies and Percentages of Marijuana Use for Pregnant Women Respondents of the
2014 NSDUH (N = 758)

Used Marijuana
Past Month
Past Year
Number of Days Used Past Year
Did Not Use
1-11 Days
12-49 Days
50-99 Days
100-299
300-365

n

%

48
122

6.3
16.1

636
30
22
16
41
13

83.9
4.0
2.9
2.1
5.4
1.7

Inferential Statistics
Research Question 1.
Pearson Chi-square was used to evaluate the potential association between past
month maternal marijuana use and residing in a state that allows or does not allow
medical marijuana use. Of the 452 women that lived in a state where medical marijuana
was not allowed, 26 (5.8%) reported that they used marijuana within the past month of
the interview. Of the 306 women that lived in a state where medical marijuana was
allowed, 22 (7.2%) reported past month use of marijuana. Pearson Chi-square analysis
(Table 4) revealed that this was not a significant association with χ2 (df = 1, N = 758) =
0.636, p = 0.425; Φ = -0.029. Therefore, the null hypothesis could not be rejected.
Research Question 2.
Pearson Chi-square was used to evaluate the potential association between past
year maternal marijuana use and residing in a state which allows or does not allow for
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medical marijuana use. Of the 452 women that lived in a state where medical marijuana
was not allowed, 68 (15.0%) reported that they used marijuana within the past year of the
interview. Of the 306 women that lived in a state where medical marijuana was allowed,
54 (17.6%) reported past year use of marijuana. Pearson Chi-square analysis (Table 4)
revealed that this was not a significant association with χ2 (df = 1, N = 758) = 0.915, p =
0.339; Φ = -0.035. Therefore, the null hypothesis could not be rejected.
Research Question 3.
Logistic regression was used to examine the potential association of living in an
area that allows medical marijuana and past month maternal marijuana use while
controlling for several covariates including age, income, education, race/ethnicity, and
marital status. Several transformations were performed due to low responses to several
subcategories. Age was transformed from four age categories to two age categories, 1425 years old and 26-44 years old. Race/ethnicity was compiled from six categories to
three categories, non-Hispanic White, non-Hispanic other, and Hispanic. The category
divorced/separated and never married was combined to form not married.
The model summary suggested that this evaluation was significant with χ2(11) =
59.556, p < 0.001. The odds ratios and significance calculations are listed in Table 5.
This model showed that state medical marijuana law, family income, education level, and
race/ethnicity were not significantly associated with increased maternal marijuana use.
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Table 4
Prevalence of Past Month and Past Year Marijuana Use for Pregnant Women
Respondents of the 2014 NSDUH (N = 758) in States that Allow Medical Marijuana and
States that do not Allow Medical Marijuana.

Past Month Use
Past Year Use

Medical Marijuana
Allowed (%)
Not Allowed (%)
7.2
5.8
17.6
15.0

p value
0.425
0.339

Φ
-0.029
-0.035

The odds ratio of pregnant women to report past month maternal marijuana use that were
25 years old or younger was higher (OR = 3.565; 95% CI: 1.379 – 9.231; p =0.009) than
pregnant women that were 26 years old or older. Unmarried women reported
significantly higher past month marijuana use than married women (OR = 6.81; 95% CI:
2.485 – 18.661; p < 0.001).
Research Question 4.
A parallel evaluation to research question 3 was executed to examine the
participant responses to past year maternal marijuana use. As before, this model was
significant with χ2(11) = 79.237, p < 0.001. Similar to the previous evaluation, state
medical marijuana law, age, family income, and education level were not significantly
associated with an increased prevalence of past year maternal marijuana use. The odds
ratio for pregnant women that were 25 years old or younger was 2.185 times higher (95%
CI: 1.294 – 3.689; p = 0.003) to report past month maternal marijuana use than pregnant
women that were 26 years old or older. Unmarried women were 4.650 times higher
(95% CI: 2.713 – 7.971; p < 0.001) to report past month marijuana use than married
women. Different from the past month maternal marijuana use analysis, past year
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maternal marijuana use analysis suggested that being Hispanic provided a degree of
protection with a 45.8% reduced odds of self-reported past year marijuana use
(OR:0.458; 95% CI: 0.252 – 0.831; p = 0.010) compared to non-Hispanic Whites (Table
6).
Table 5
Past Month Use Reported by Pregnant Respondents of the 2014 NSDUH (N = 758)
β

SE

Odds
Ratio

P

Confidence
Intervals

Medical Marijuana
Not Allowed
Allowed

ref
0.424

ref
0.320

ref
1.52

ref
0.185

ref
0.816 - 2.859

Age Group
14-25
26-44

1.271
ref

0.484
ref

3.565
ref

0.009
ref

1.379 – 9.213
ref

Family Income
Less than $20,000
$20,000-$49,999
$50,000 - $74,999
$75,000 or more

0.129
0.359
-0.157
ref

0.571
0.549
0.718
ref

1.138
1.433
0.855
ref

0.821
0.513
0.827
ref

0.372 – 3.482
0.488 – 4.203
0.209 – 3.490
ref

0.619
-0.007
0.597
ref

0.739
0.736
0.705
ref

1.858
0.993
1.817
ref

0.402
0.992
0.397
ref

0.437 – 7.901
0.235 – 4.202
0.456 – 7.239
ref

Race Ethnicity
Non-Hispanic White
Non-Hispanic Other
Hispanic

ref
-0.122
-0.885

ref
0.359
0.460

ref
0.886
0.413

ref
0.735
0.054

ref
0.438 – 1.789
0.168 – 1.017

Marital Status
Married
Not Married

ref
1.918

ref
0.769

ref
6.810

ref
<0.001

ref
2.485 – 18.661

Education Level
Did not finish high school

High School Graduate
Some College
College Graduate
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Table 6
Past Year Use Reported by Pregnant Respondents of the 2014 NSDUH (N = 758)
β

SE

Odds
Ratio

P

Confidence
Intervals

Medical Marijuana
Not Allowed
Allowed

ref
0.375

ref
0.215

ref
1.456

ref
0.081

ref
0.955 – 2.220

Age Group
14-25
26-44

0.782
ref

0.267
ref

2.185
ref

0.003
ref

1.294 – 3.689
ref

Family Income
Less than $20,000
$20,000-$49,999
$50,000 - $74,999
$75,000 or more

0.238
0.139
0.265
ref

0.362
0.341
0.388
ref

1.269
1.149
1.304
ref

0.511
0.684
0.494
ref

0.624 – 2.580
0.589 – 2.243
0.610 – 2.790
ref

0.005
-0.587
-0.121
ref

0.397
0.388
0.360
ref

1.005
0.556
0.886
ref

0.989
0.130
0.736
ref

0.462 – 2.190
0.260 – 1.188
0.438 – 1.792
Ref

Race Ethnicity
Non-Hispanic White
Non-Hispanic Other
Hispanic

ref
-0.229
-0.781

ref
0.248
0.304

ref
0.796
0.458

ref
0.357
0.010

ref
0.489 – 1.294
0.252 – 0.831

Marital Status
Married
Not Married

ref
1.537

ref
0.335

ref
4.650

ref
<0.001

ref
2.713 – 7.971

Education Level
Did not finish high school
High School Graduate
Some College
College Graduate

Research Question 5.
Chi-squared analysis was used to evaluate the association of state medical marijuana laws
on the level of self-reported maternal marijuana use. The response to the question of how
many days did you use during the past year was transformed into a dichotomous variable
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(Table 7). The self-reported use of marijuana for 1-99 days during the past year defined
light use. One hundred (100) or more days of self-reported marijuana use identified
heavy use.

Table 7
Level of Past Year Marijuana Use for Pregnant Women Respondents of the 2014
NSDUH (N = 758) in States that Allow Medical Marijuana and States that do not Allow
Medical Marijuana.

Light Use (1-99 days)
Heavy Use (≥ 100 days)
p = 0.061, Φ = -0.169

Allowed (%)
25 (46)
29 (54)

Medical Marijuana
Not Allowed (%)
43 (63)
25 (37)

Of the 68 women who reported past year marijuana use that lived in a state where
medical marijuana use was not allowed, heavy users accounted for 25 (36.8%) of the
respondents. Of the 54 women who reported past year marijuana use that lived in a state
where medical marijuana was allowed, the proportion of heavy users increased to 29
(53.7%) . Pearson Chi-square analysis (Table 6) revealed that this was not a significant
association with χ2 (df = 1, N = 122) = 3.501, p = 0.060; Φ = -0.169. Although very close
to p = 0.05 the null hypothesis could not be rejected.
Summary
This chapter presented the results of the secondary analysis with regard to
statewide medical marijuana laws and self-reported maternal marijuana use using the
2014 NSDUH. Women responding in the affirmative to the question of being pregnant
were selected and categorized into two groups, those that resided in a state that allowed
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medical marijuana at the time of the interview and those that did not reside in a state that
allowed medical marijuana.
The survey recorded the responses of 758 pregnant women and analyzed for
prevalence and usage level. The prevalence of self-reported maternal marijuana use was
higher for both past month (7.2% versus 5.8%) and past year (17.6% versus 15.0%) use
for women living in states that allow medical marijuana, however, in both instances the
increases were not significant (p = 0.425 and p = 0.339, respectively). Additionally,
when controlling for age, family income, education, race/ethnicity, and marital status, no
significant association existed between state medical laws and maternal marijuana use.
Heavy use (using 100 days or more per year) was higher in states that allowed medical
marijuana (54% compared to 37%) than in states that did not allow medical marijuana.
Chapter 5 includes a discussion of the significance of these findings in the context of
current knowledge, limitations of the study, recommendations for further research, and
implications for positive social change.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
Maternal marijuana use is a significant public health issue due to the long term
negative neurobehavioral deficits seen in children born to these mothers. Many states are
relaxing their marijuana policies to include medicinal and recreational use, creating a
general environment of reduced perception of risk of use. This change created an
environment where the potency of marijuana increased dramatically over the past 2
decades and marijuana has become much more accessible (ElSohly et al., 2016). There
are numerous studies evaluating the potential association between residing in a state
where medical marijuana use is allowed and adolescent use initiation, increased use in
selected minorities, and increased use in the general population (Wall et al., 2011; Harper
et al., 2012; Schmidt et al., 2016; Chasnoff, 2017). However, studies evaluating the
association of medical marijuana laws and maternal marijuana use are lacking in the
literature. The purpose of this study was to fill that gap in the literature.
Interpretation of Findings
Research questions 1 and 2 were composed to evaluate the differences of past
month and past year maternal marijuana use in states that allow medical marijuana use
and states that do not allow medical marijuana. This study demonstrated that the
prevalence of maternal marijuana use was higher in states where medical marijuana was
allowed for both past month (7.2% compared to 5.8%) and past year use (17.6%
compared to 15.0%). However, in both cases, the increase was not statistically
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significant (p = 0.452 and p = 0.339, respectively). This observation was similar to
findings of another vulnerable population, adolescents, which was reviewed in Chapter 2.
Several studies have specifically reviewed adolescent marijuana use using
NSDUH data with mixed results. Wall et al. (2011) compared adolescent marijuana use
between 2002 and 2008 in states where medical marijuana was allowed compared to
states where it was not allowed. They reported a higher average adolescent marijuana
use in states where medical marijuana was allowed (8.68% compared to 6.94%). Due to
its cross-sectional design, this study did not attribute the increase solely to the allowance
of medical marijuana use in given states.
Harper et al. (2013) evaluated the same data set using a more complex design in
an attempt to isolate the influence over time of the presence of medical marijuana laws on
adolescent marijuana use. Harper et al. (2013) confirmed an increase in adolescent
marijuana use in states with medical marijuana laws observed by Wall et al. (2011).
However, when applying a more complex analysis using a difference in differences
approach they reported that the passage of medical marijuana laws presented no
significant affect (β = -0.53; 95% CI: -1.0, 0.0).
Stolzenberg, D’Alessio, and Dariano (2016) recently reviewed NSDUH results
but chose to use a cross-sectional, pooled-time series in 2 year increments from 20022011. Stolzenberg and colleagues (2016) geocoded the data and created dummy
variables to reflect the timing of the passage of state law as well as other elements of the
laws, including possession limits and product availability. They also confirmed increased
levels of adolescent marijuana use in states that allowed medical marijuana, and when
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controlling for a number of other factors such as possession limits and availability, they
observed a statistically significant influence of the presence of medical marijuana laws (β
= 0.861; p = <0.001).
The purpose of research questions 3 and 4 was to investigate the differences of
past month and past year maternal marijuana use in states that allow medical marijuana
use and states that do not allow medical marijuana use while controlling for age, family
income, educational level, race/ethnicity, and marital status. Controlling for these
demographic elements did not reveal a significant influence of state medical marijuana
laws (β = 0.424; p = 0.185) on self-reported maternal marijuana use. Additionally, there
was no apparent statistically significant influence observed for family income level or
educational level. However, as demonstrated in other studies of other populations, there
was an association between maternal marijuana use and age, marital status, and
race/ethnicity.
Young mothers between the ages of 14-25 years old self-reported more past
month use during pregnancy (OR = 3.565; 95% CI: 1.379, 9.213; p = 0.009) and past
year use during pregnancy (OR = 2.185; 95% CI: 1.294, 3.689; p = 0.003). The odds
ratio for unmarried women was 6.81 times higher for past month use than married
women (95% CI: 2.485, 18.661; p < 0.001) and 4.650 times higher for past year use (95%
CI: 2.713, 7.971; p < 0.001). However, being Hispanic provided an apparent degree of
protection, where the odds ratio was less than half to report maternal marijuana past
month use (OR = 0.413; p = 0.054; 95% CI: 0.168, 1.017) and past year marijuana use
(OR = 0.458; p = 0.010; 95% CI: 0.252, 0.831) compared to non-Hispanic Whites.
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A study of the responses to the National Epidemiologic Survey on Alcohol and
Related Conditions (NESARC) showed a similar trend of use by age in the general
population (Hasin et al., 2015). Among 18-29 year olds, 10.5% reported past-year
marijuana use compared to the next highest age group (30-34 years old) only reporting
4.1% in the NESARC Wave I in 2001-2002 (Hasin et al., 2015). NESARC Wave II
(2012-2013) showed past year marijuana use of 18-29 year olds at 21.2% compared to
30-34 year olds at 10.1%. Ko et al. (2015) showed in their study of the NSDUH (20072012) that over half of the pregnant mothers reporting past month marijuana use were
between the ages of 18-25 years old (66.7%), which was similar to their findings among
non-pregnant females ages 18-25 years old (54.8%). These findings consistently showed
that young people, whether pregnant or simply part of the general population, were at
higher risk to self-report marijuana use.
Marital status has also been a consistent predictor of self-reported marijuana use.
The 2012-2013 Wave II of the NESARC showed that unmarried people (21.0%) were
much more inclined to report past year marijuana use than widowed/separated people
(8.3%) or married individuals (5.5%; Hasin et al., 2016). The NSDUH (2007-2012) data
showed that 70.4% of pregnant women that reported past month marijuana use were
never married (Ko et al., 2015). Saurel-Cubizolles and Blondel (2014) also observed this
trend in a French national study where the odds of women that did not cohabitate with the
child’s father were 1.69 times higher (95% CI: 1.01, 2.82; p < 0.05) to report marijuana
use during pregnancy than pregnant women cohabitating with their partner.
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Race/ethnicity provided an interesting comparison, in which Hispanics tended to
self-report less marijuana use than Non-Hispanics. In the NESARC Wave II in 2012 and
2013, Hasin et al. (2015) observed in the general population a prevalence of past year
marijuana use of 8.4% while non-Hispanic Whites and Blacks reported use at much
higher rates (9.4% and 12.7%, respectively). Ko and colleagues (2015), reported in their
study using the NSDUH (2007-2012) that pregnant Hispanic women were less inclined to
report past year marijuana use (OR = 0.6; 95% CI: 0.4, 0.8) when compared to NonHispanic Whites.
The purpose of research question 5 was to evaluate a potential increase in heavy
marijuana use among pregnant women in states that allow medical marijuana use
compared to pregnant women who lived in states that do not allow medical marijuana
use. Light marijuana use was defined as using 99 days or less per year while heavy use
was defined as using 100 or more days per year. Of the pregnant women that reported
past year marijuana use living in a state that does not allow medical marijuana use, 37%
self-reported as heavy users. In states that allowed medical marijuana use, 54%
categorized as heavy users. While this was a large increase, the finding approached
statistical significance (p = 0.061).
This finding is consistent with a recent report evaluating concentrations of
marijuana metabolite (THCA) in newborn meconium before and after legalization of
recreational marijuana use in Colorado (Chasnoff, 2017). Meconium is the first fecal
material excreted by the newborn that has accumulated in the large intestine of the
neonate during the second and third trimesters (Gareri, Klein, & Koren, 2006).
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Meconium has been considered for many years to be the gold standard specimen type to
determine prenatal drug exposure because of its long window and detection, availability,
and noninvasive collection procedure (Gareri et al., 2006).
Chasnoff (2017) referred to preliminary data indicating that a significant increase
in the prevalence of positive meconium specimens was not observed following the
implementation of recreational marijuana law in Colorado. However, there was a
significant increase in the observed mean concentrations of THCA found in newborn
meconium following implementation of the Colorado law (213 ± 230 ng/g compared to
361 ± 420 ng/g; p = 0.013) which indicated an increase in heavy marijuana use among
those that chose to use. This observation aligns with the findings reported here where an
increase of heavy users over light users was observed in states that allow for medical
marijuana.
Analysis of theoretical framework
I selected the theory of planned behavior as the theoretical framework to ground
this study. The theory proposes that performing behaviors such as exercise, dieting, drug
use initiation, drug use maintenance, or drug use cessation precede the intention to
perform the behavior (Ajzen, 1991). The magnitude of the intention is proportional to the
probability the individual will perform the behavior (Ajzen, 1991). Attitude, subjective
norms, and perceived behavioral control influence the intention to perform a behavior.
The presence of a statewide policy allowing medical marijuana represents a
subjective norm expected to influence the intention to use marijuana. If the state
approves the use of marijuana, the expectation of a decrease of the negative perception of
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marijuana use exists. The increased pervasiveness of marijuana in the environment to
satisfy the medical marijuana demand makes obtaining marijuana easier, which increases
perceived behavioral control. The findings reported in the study are supported by the
theory of planned behavior because although technically not statistically significant, the
observed increases in prevalence and amount of use were in the expected direction
predicted by the theory.
Limitations
The major advantages of using the NSDUH were the size, and inclusion of the
new question about the presence of medical marijuana law at the time of inquiry. The
NSDUH reports the national sampling of close to 60,000 participants, which included
758 pregnant women. The NSDUH employed a complex sampling strategy to ensure that
the respondents were an accurate representation of the national demographic. Inclusion
of the new questionnaire item indicating the presence of state medical marijuana laws at
the time of interview allowed for simple yet accurate categorization of the dependent
variable.
The most significant limitation to this study was its reliance on self-report of drug
use behavior. The prevalence and extent of marijuana use was expected to be underreported due to reasons of self-incrimination and stigma. McDonald (2008) concluded
that individuals in general answer questions in a manner that is more socially acceptable.
The survey attempted to mitigate these concerns by conducting the interview in a private
area away from others and by the use of a computer assisted protocol.
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The NSDUH does not include institutionalized, incarcerated, or homeless
individuals in their survey. Historically, these populations have been at high risk for
substance use and abuse. A survey conducted by the U.S. Bureau of Prisons reported that
53.4% of state prison inmates and 45.5% of federal prison inmates met the Diagnostic
and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) requirements of
drug dependence or abuse (Mumola & Karberg, 2006). According to the U.S.
Department of Housing and Urban Development (2016), of the approximately 550,000
homeless individuals in the United States, up to 20% suffered from long term ongoing
substance use and abuse issues. Inclusion of these demographics would have
disproportionately increased the number of users in the study and perhaps altered the
outcome.
Lastly, this survey did not capture information regarding the participants residing
in a state that adopted a recreational marijuana law. At the time of this survey, two states
(Colorado and Washington) had adopted policies that allowed for recreational marijuana
use in addition to medical marijuana use (NAMSDL, 2016). The influence of a state
recreational marijuana law may not be equivalent to that of a state medical marijuana
law. This study only considered the presence of statewide medical marijuana laws and
may underestimate increases which may be observed in areas that permit recreational use.
Recommendations
Maternal marijuana use has been associated with a number of long-term negative
neurobehavioral consequences for newborns (Minnes & Singer, 2011). In contradiction
to the HealthyPeople 2020 goal of reducing maternal drug use (including marijuana),

80
there has been a long term trend of increased permissive views among adolescents
concerning marijuana use (Schmidt, Jacobs, & Spetz, 2016) and an increase in the
number of jurisdictions that allow medical and recreational marijuana (NAMSDL, 2016).
This environment, coupled with the findings of this study, warrant further investigation
on the factors associated with maternal marijuana use. I recommend that this study be
replicated with subsequent waves of NSDUH, with the inclusion of marijuana use
questions as general core questions in the Pregnancy Risk Assessment Monitoring
System (PRAMS), and inclusion of an objective long term biomarker in a survey of
neonates coming from various geographical areas.
The 2014 NSDUH was the first wave of NSDUH that included survey item
MEDMJST2, which is a dichotomous variable indicating the allowance of medical
marijuana in the participant’s state of primary residence at the time of interview. The
inclusion of this variable in this and subsequent surveys allows for accurate and simple
evaluation of the prevalence and extent of marijuana use among a variety of
demographics including pregnant women. As the number of states that allow medical
marijuana increase, replicating this study over time may provide useful insight. An
additional improvement may be in the inclusion of a variable indicating the allowance of
recreational marijuana use in subsequent rounds of the NSDUH survey.
The PRAMS survey, sponsored by the CDC, includes a common core set of
questions and participating states around the country execute the survey post-partum.
Each State’s Department of Health may also include an additional battery of questions of
local concern. At this time, only the State of Hawaii includes a question concerning
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maternal marijuana use. Inclusion of a question concerning maternal marijuana use in the
PRAMS general core may provide improved accuracy because the survey is not
performed while the mother is pregnant but is conducted following the birth of the child.
In instances where the child is apparently healthy, the reduction of potential stigma
encourages the mother to more accurately self-report marijuana use during pregnancy.
Lastly, I recommend the inclusion of a long term biomarker of marijuana
consumption in a national survey to improve the accuracy of monitoring maternal
marijuana use. Maternal marijuana use is under-reported using self-report strategies due
to self-incrimination and negative stigma reasons (Ko et al., 2015). The detection of
THC and/or its metabolites in biological specimens such as meconium, umbilical cord
tissue, and hair can provide useful and objective information concerning in utero drug
exposure (Chasnoff, 2017; Gray & Huestis, 2007). Additionally, informing participants
about the inclusion of a biological measure in a survey improves self-report accuracy
(Hahn et al., 2012).
Implications for Positive Social Change
An association exists between in utero exposure to marijuana and long-term
neurobehavioral deficits and these marijuana induced deficits are 100% preventable. The
results of this study confirm previous reports in that marijuana use in jurisdictions that
allow medical marijuana, while statistically insignificant, are higher than in jurisdiction
that do not allow for medical marijuana. Furthermore, among those that reside in states
that allow medical marijuana and that choose to use during pregnancy, use more
frequently than their counterparts in states that do not allow medical marijuana. This
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study also aligns with previous reports stating that younger and unmarried women are at
higher risk of maternal marijuana use than other women. These findings along with
increasing permissive views of marijuana use among adolescents and an increase in the
number of states that allow medical marijuana use demand that policymakers direct
prevention efforts to these higher risk group.
The increase of permissive views of marijuana use among adolescents presents a
compounded set of public health issues. An association between age of substance use
initiation and higher substance dependency later in life exists. Additionally, the
adolescent demographic are entering into the reproductive age range. Policymakers in all
jurisdictions but especially in those jurisdictions that either allow medical marijuana or
are considering the allowance of medical marijuana should focus substance use
prevention resources to their adolescent constituents including information concerning
the long term neurobehavioral deficits associated with maternal marijuana use.
Policymakers in all states but especially in states that allow medical marijuana or
states considering the allowance of medical marijuana should provide additional
resources for substance use prevention for young unmarried women. This study was
consistent with previous reports showing that these two characteristics are at a
statistically significant increased risk over other demographics studied. Additionally,
young, unmarried women are more apt to not have adequate healthcare coverage which
may present a barrier to prenatal treatment and a conduit for substance use prevention
efforts.
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The most important social change implication emanating from this study is the
need to improve maternal access to information about the long term negative
neurobehavioral deficits associated with maternal marijuana use. The literature review
presented here clearly demonstrates the association between maternal marijuana use and
long-term neurobehavioral deficit among babies. The study findings, while statistically
insignificant, show consistently higher rates of maternal marijuana use in states that allow
medical marijuana than in states that do not allow medical marijuana. Additionally, in
states where medical marijuana is allowed, mothers that used marijuana used more than
their peers in states that did not allow medical marijuana. However, a recent study of
pregnant women’s access to information regarding the potential harmful effects of
prenatal marijuana exposure was disappointing (Jarlenski, Tarr, Holland, Farrell, &
Chang, 2016).
Jalenski et al. (2016) noted that women mostly relied on internet searches for
prenatal marijuana exposure information and the experiences of family or friends. This
study only included women with access to prenatal care yet only a few of the pregnant
women received pertinent information concerning prenatal marijuana exposure from their
healthcare provider (Jalenski et al., 2016). The participants reported the desire to obtain
specific information concerning the potential of harmful effects of maternal marijuana
use and for those that did receive feedback they questioned the quality of the information
they received (Jalenski et al., 2016). The findings of Jalenski et al. (2016) coupled with
the findings of this study identify an opportunity for policymakers and public health
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professionals to intervene in this vulnerable population with targeted substance use
prevention efforts to initiate positive social change.
Conclusion
The study presented here evaluated, for the first time, the association of maternal
marijuana use for women that reside in states that allow medical marijuana and women
that reside in states that do not allow medical marijuana. The prevalence of past-month
and past-year maternal marijuana use was higher for women that resided in states that
allowed medical marijuana, however, that increase was not statistically significant. The
proportion of heavy users (defined as using 100 days or more during the past year) in
states that allow medical marijuana compared to light users (using 99 days or less during
the past year) was higher compared to their marijuana using peers in states that do not
allow medical marijuana. This finding approached statistical significance (p = 0.06). In
addition, the findings presented here were consistent with other reports that show young
and unmarried pregnant women to be at higher risk of self-reported marijuana use.
Maternal marijuana use is associated with negative long term public health consequences
and coupled with these findings present an opportunity for public health policymakers
and healthcare professionals to provide targeted intervention for positive social change.
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